Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½...

38
RBHraCaNacRkkm<úCa KINGDOM OF CAMBODIA Cati sasna RBHmhakSRt NATION RELIGION KING RksYgsuxaPi)al MINISTRY OF HEALTH r)aykarN_ skmμPaBRKb;RCugeRCay kmμviFIbgáar nigEfTaM CMgWeGds_¼kameraK RbcaMRtImasTI 2 qñaM 2011 SECOND QUARTERLY COMPREHENSIVE REPORT, 2011 HIV/AIDS & STI PREVENTION AND CARE PROGRAMME mCÄmNÐ lCatiRbyuT§nwgCMgWeGds_ esIEs,k nigkameraK NATIONAL CENTRE FOR HIV/AIDS, DERMATOLOGY AND STD

Transcript of Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½...

Page 1: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

RBHraCaN acRkkm<úCa KINGDOM OF CAMBODIA

Cati sasna RBHm hakSRt NATION RELIGION KING

RksYgsuxaP i)al MINISTRY OF HEALTH

r)aykarN _ sk mµPaBRKb;RCugeRCay kmµviFIbgáar nigEfTaM

CMgWeGds_¼kameraK RbcaMRtImasTI 2 qñaM 2011

SSEECCOONNDD QQUUAARRTTEERRLLYY CCOOMMPPRREEHHEENNSSIIVVEE RREEPPOORRTT,, 22001111

HHIIVV//AAIIDDSS && SSTTII PPRREEVVEENNTTIIOONN AANNDD CCAARREE PPRROOGGRRAAMMMMEE

mCÄm NÐl CatiRbyuT §nwg CMgWeGds _ es IEs ,k n igkameraK NATIONAL CENTRE FOR HIV/AIDS, DERMATOLOGY AND STD

Page 2: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

ntlmBB~tHt~rujjl~ lPt1t~stl~EUH:lW ifd~tujll stlmmni:i §ftJB~ytlHOm~lliltlrn , ,

BrnmtliH'd ~tlruUlSB~BlUtl~lPtl ntlmm~J~Sm~!1GU~l7 -h~m StlrlJlUlruijll~mmni1 , 1

AI

6§~. £lS mm~~

aa~tUmt3ooJfJ~gjUlitU~§5b

d6~aatl~ UiulliOJfJ 5bmfJUleJ

Page 3: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

2

Acronyms

AHF AIDS Health Care Foundation m UlniF iE f T aMCMg We G ds _ ANC Antenatal Care ka rE fT aMé pÞeB a Hm un eB ls Mra l

AOCP Annual Operational Comprehensive Plan E pn k a rR bt ibt þiR b caMq ña MR Kb ;R Cu g eR Ca y

ART Antiretroviral Therapy k a rB üa ) a leda y»s f R bqa Mg em era KeG ds _ AHEAD Action for Health Development

ARV Antiretroviral »sf R bqa Mg em era KeG ds _ AFD Association of Farmer Development sm a Km GPiv D Æn _ k s ik r BCC Behaviour Change Communication k m µviF IE dl na M[m a n k a rpøa s ;b þÚrk a rR bR Bwt þ BSS Behavioural Sentinel Surveillance k a rG eg át ka rR b RB wt þp øÚveP T

BFD Buddhism for Development GgÁk a rB uT §s a sn a ed Im ,IG Piv D Æn _ BWAP Battambang Women’s Aids Project k m µv iF IR s þIG b ;rM Cm ¶We G ds _ e xt þ) a t ;d Mbg

CENAT National TB Programme m CÄm NÐlCa t ik Mc a t ;era Krebg n ig h g ;s in

CHBC Community Home-based Care k a rE fT a MG ñk CMg WeG ds _en A t a m p ÞH n ig enA k ñúg sh Km n _

CHC Cambodian Health Committee

CDC Center for Disease Control

CHAI Clinton Foundation for HIV/AIDS Initiative m Uln iF i Kø It un E f T aMCMg WeG ds _ CoC Continuum of Care k mµviF IE f T a Mnig B üa )a lb nþdl;G ñ k pÞúk em era KeG ds _ ¼G ñk CMg We G ds _

CoC-CC Continuum of Care Coordinating Committee

KN³ k m µk a rs Mrbs MrY lk m µv i F IE f TaMn ig B üa ) a lbnþdl ;G ñ k p Þúk em era KeG ds _¼ Gñk CMg We G ds _ CRS Catholic Relief Services

CTAP Cambodian Treatment Access Programme

CIPRA Comprehensive International Program for Research on AIDS

CTC Care and Treatment Component

CPN+ Cambodia People Living with HIV/AIDS Network

b Nþa j én G ñk p Þúk em era KeG ds _¼G ñk CMg WeG ds _k ñúg R B Hra Ca Na cR k k m <úCa CMS Central Medical Store

CSCN Cambodia Save Children Network bNþa j s e®g Áa Hkum a rk m<ú Ca

Page 4: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

3

CUCC Condom-Use Coordinating Committee

KN³ k m µk a rs Mrbs MrY lk m µv i F IeR b IR) a s;eR sa m G n a m½y 1 00 °

CUP Condom-Use Programme km µv iF IeR b IR ) a s ;eR s a mG na m ½y1 0 0°

CUWG Condom-Use Working Group Rk um k a rg a rkm µv iF Ie R b IR ) a s ;eRs a m G n am ½y10 0°

CWPD Cambodian Women for Peace and Development

s m a Km n a rIk m <úCa ed Im , Isn þ iP a B n ig G Piv D Æn _ CQI Continuum Quality Improvment

DFID Department for International Development

DU Drug Use eR b IR) a s;eR KO g ej on

DSW Direct Sex Worker R s þIr k s uIpøÚv ePT enA t a m pÞHbn

DTOP District Team on Outreach & Peer education Rk um G b;rMp Þa l; m it þG b ;rMm it þf ña k ;R s uk

D-CoPCT-CC District Continuum of Prevention to Care and Treatment Coordination

Committee KN³ k m µa k a rs Mrbs Mr Ylk a rg a rbg áa r E f Ta M B üa )a lbn þf ñak ;R s uk

DPCT District Prevention to Care Team Rk um pþl;es va b gáa rf ña k;R s uk

EW Entertainment Worker

EWI Early Warning Indicator

FI Friend International Gg Áka rm it þs MLa j ; FHI Family Health International GgÁk a rs uxPa B G n þrCa ti FHC Family Health Clinics

GFATM The Global Fund to fight AIDS, Tuberculosis, and Malaria

KMe ra g m Ul niF isk l

HAART High Active Antiretroviral Therapy

HBC Home Base Care

HC Health Center m NÐls uxPa B HFBC Health Facility Based Care ka rE fT a MG ñk CMg WeG d s _en A k ñúg m nÞIreB T ü

HIV Human Immunodeficiency Virus

HSS HIV Sentinel Surveillance ka rG egát G R ta eR bv :a Lg ;em era K

IEC Information, Education & Communication

Page 5: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

4

ICF International Classification of Functioning

IC Infection Control

IPT Isoniazid Preventive Therapy

IRD Immune Restoration Disease

ITM Institute of Tropical Medicine

KYA Khmer Youth Association sm a Km yuv Cn E x µr KWCD Khmer Women’s Cooperation for Development

KHANA Khmer HIV/AIDS NGO Alliance Gg Áka rsm <½n §P a B E xµrR b yuT §n wg CMg WeG ds _ LR Link Response ka req øIyt brYm Kña LoA Letter of Agreement

LFA Local Fund Agency T IPña k;g a rem IlCMn YyR bc a MR beT s s Mra b ;m Uln iF isk l

MoH Ministry of Health Rk sYg s uxa Pi) a l

MoSVY Ministry of Social Veteran and Youth Rehabilitation

R k sYg s gÁm k ic ©G tIt yuv Cn nig yuvn It is m ,T a MMM Mondol Mith Chouy Mith m NÐlm it þCYym it þ MSM Men who have Sex with Men b ursrYm ePT Ca m Y y b urs MSC Marie Stopes Cambodia Gg Ák a rm :a rIs þúb k m <úCa MSIC Marie Stopes International Cambodia

M & E Monitoring and Evaluation

NAA National AIDS Authority Ga CJa FrCa t iR byuT §nwg CM g WeG ds _

NCHADS National Centre for HIV/AIDS, Dermatology and STI

m CÄm NÐl Ca t iR byuT §n wg CM g WeG ds _ es IE s ,k n ig k a m era K

NGO Non-Governmental Organization G gÁk a rmin E m nrd æa Pi) a l

NIPH National Institute of Public Health v iT üa s ßa nCa t iRs a vR Ca v s uxPa B sa Fa rN³ NPH National Pediatric Hospital m nÞIreB T ük um a rCa t i

NMCHC National Maternal Child Health Center m CÄm NÐl Ca t iKa MB a m at a n ig T a rk

OD

Operational District Rs uk R bt ibt þi

OI Opportunistic Infection CMg W»k a sn iym

OPC Outreach, Peer Education and Condom Use Program k m µviF IG b ;r MpÞa l;

Page 6: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

5

n ig m it þG b ;rMm it þ n ig k m µv iF IeR b IR ) a s;eR sa m G n a m½y 1 0 0 ° PAO Provincial AIDS Office k m µviF IR byuT §n wg C Mg WeG ds _e xt þ-R k ug PC Partner in Compassion GgÁk a rédKU pþl; em t þa

PBSI Performance Based Salary Incentive R ) ak;] bt ßm ÖelIk T wk c it þt a m s ña édk a rgar PHD Provincial Health Department m n ÞIrs uxa P i) a le x t þ

PLHIV People Living with HIV/AIDS Gñk pÞúk em era KeG ds _¼G ñk CMg WeG ds_ PMR Planning, Monitoring and Reporting E pñk E p nk a rta m da n nig r) a yka rN_

PMTCT Prevention of Mother-to-Child Transmission [of HIV]

k m µviF Ibg áa rc Mlg em era KeG ds _B Im þa yeT A T a rk

PRTRT Principle Recipient Technical Review Team

PREDICT Pediatric Randomized of Early and Deferred Initiative in Cambodia and Thailand

PSI Population Services International Gg Ák a rb MerIs u xP a B R bCa CnG n þr Ca t i PSF Pharmacist Sans Frontiers

PST/OP Provincial Support Team on Outreach & Peer education

R k um Ka MR T k mµv iF IG b ;r Mp Þa l; n i g mit þG b ;rMm it þf ña k ;ext þ

P-CoPCT-CC Provincial Continuum of Prevention of Care and Treatment Coordination

Committee KN³ k m µa k a rs Mrbs Mr Ylk a rg a rbg áa r E f Ta M B üa )a lbn þf ñak ;ext þ

P-CoPCT-ST Provincial Continuum of Prevention of Care and Treatment Support

Team Rk um Ka MR T k a rga rb gáar Ef Ta M B üa) a lb nþf ña k;ext þ QC Quality Control k a rRt YtB init üKu NPa B RH Referral Hospital m n ÞIre B T übEg¥k

RHAC Reproductive Health Association of Cambodia sma Km r:a k ;k m<úCa RACHA Reproductive and Child health Alliance sm <½n§ s uxPa B kum a r n ig s uxPa B bn þB UC

SCA Save the Children Australia

SEADO Social Environment Agricultural Development Organization G g Ák a rG Piv D Æn _sg Ám bris ßa n n ig k sik m µ

SEAD Sharing Experience Adapted Development

SOP Standard Operating Procedures niya m E bb bT sMra b ;R bt ibt þi SSS STI Sentinel Surveillance ka rG eg át G R t a eR bv:a Lg ;CMg Wk a m era K

STI/RTI Sexually Transmitted Infection/ Reproductive Tract Infection

Page 7: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

6

k a rbg áera Kt a mk a rrYm ePT n ig R b da b ;bn þB UC

SW Sex Worker R s þIrk s uIpø Úv e PT

SR Sub Recipient

TWG Technical Working Group Rk um k a rg a rbec ©k eT s UNAIDS United Nations Joint Programme on AIDS

UNFP United Nations Population Fund

UNSW University of New South Wales

VCCT Voluntary Confidential Counseling and Testing

m NÐl eF V Iet s þQ a m rk em eraKeG ds _ eda ys µR ½ K c it þ n ig r k Sa k a rsMg at ; WB World Bank Fn a Ka rB iPB ela k

WHO World Health Organization G gÁk a rs uxP a B B iPB el a k

WOMEN Women Organization for Modern Economy and Nursing

s m a Km n a rIG Piv D Æn _esd æk ic© nig G n a m½y

WVC World Vision Cambodia Gg Ák a rT s Sn³ B iP B el akk m <úCa

Page 8: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

7

PROVINCES

BMC : Banteay Mean Chey ext þbn Þa ym a n C½ y BTB : Battambang ext þ) a t ;d Mbg

KCM : Kampong Cham ext þk MB g;c a m

KCN : Kampong Chhnang ext þk MB g;q ña Mg

KDL : Kandal ext þk Nþa l

KEP : Kep Rk ug E k b

KHK : Koh Kong ext þek a Hk ug

KPT : Kampot ext þk MB t

KTM : Kampong Thom ext þk MB g;F M KRT : Kratie ext þR k ec H KSP : Kampong Speu ext þk MB g;s <W MDK : Mondulkiri ext þm N Ðl KIr I OMC : Oddor Mean Cheay ext þ]t þ rm a n C½ y

PLN : Pailin Rk ug é b :lin

PNP : Phnom Penh ra CFa nIP ñMeB j

PST : Pursat ext þeB a F isa t; PVG : Prey Veng ext þéR B E vg

PVH : Preah Vihear ext þR B Hvih a r RTK : Rattanakiri ext þrt n KI rI SHV : Sihanouk Ville Rk ug RB Hs Ihn u SRP : Siem Reap ext þes o m ra b

SVR : Svay Rieng ext þs Va ye ro g

STG : Stung Treng ext þs Þ wg E R t g

TKV : Takoe ext þt a E k v

Page 9: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

8

mmaattiikkaa eesscckkþþ II eeppþþ IImm 11>> kkaarrRRKKbb;; RRKKgg nniiggGGnnuuvvttþþnn__kkmmµµvviiFFII

k > k arRKb ;RK gKMe rag C MnY yé nm Ul ni Fis k l x > k a rG nuvtþn_k m µv iFIrb s ; mC ÄmN Ð l Ca t i ³ 1 > k Ba ©b ;s Mr a b;b g áa r 1 > k Ba ©b ;s Mr a b;b g áa r 1 > k Ba ©b ;s Mr a b;b g áa r 1 > k Ba ©b ;s Mr a b;b g áa r

k > k mµv iF IE d ln a M[m a n k a rpø a s ;b þÚrk a rR bRB wt þ

x> k m µviF IR b yuT §n wg CMg Wk a m era K n ig k a rbg áera Ken A R bda b ;b nþB UC

2> k Ba ©b;s Mra b;E fTa M n igBü a) a l bnþd l ;Gñk p Þúkem er a KeG ds_ n igG ñkC Mg WeG ds _ k > k a rEf TaMG ñk CMg WeGds _ en A kñúg m n ÞIreB T ü n ig en A t a m p ÞH nig en A k ñúg sh Km n _ x> k a rpþl ;R b wk Sa nig eFVIet s þ Q a m rk em era KeG ds _ eda ys µR K½c it þ n ig rk Sak a rs Mga t ;

3> kBa ©b ;G eg át n igR s a vR Ca v k > k a rG egát t a m da n

x> k a rsik Sa R sa v R Ca v 4> kBa ©b ;R K b ;R K g

k > E pn k a r ta m da n n ig va yt Mél x> k a rR Kb ;R Kg T in ñ½ y K> k a rR Kb ;R Kg »s f n ig s MPa r³ brik ça r

22>> llTT§§ppllEEddllTTTTYYll))aannBBIIkkaarrppþþll;;eessvvaassuuxxaaPPii))aall 1 sk mµPa B bg áa r én em era K e G ds _ ¼ CMg WeG ds _

2222 es va E f T aMdl;G ñk p Þ úk em era k eG ds _ n ig G ñk CMg WeG ds _ 2>1 > esv a eF VIet s þQ a m rk em era KeGds _ eda ys µR ½Kc it þ n ig rk Sak a rs Mg a t ; 2>2 es va E f T aM nig B üa )a lCMg W» k a s niym nig k a rB üa )a leda y»sf Rb qaMg nwg em era KeG ds _

k > k a rKa MR TE pñk m n ÞIrB iesa F n_ x> k a rc l½t G ñk CMg W t a m es va ep Sg ² K> k a rKa MR TE pñk »s f n wg smÖar³ brik ça r

Page 10: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

9

X > k a reFVIIet s þR sa v R Ca v rk CMg Wr ebg elIG ñk CMg WeG ds _f µI g > k a rG n uvt þn_yuT §sa R s þ Three I h > k m µv iF Ieq øI yt b rYm Kña

2>3 k m µviF Ieq ø Iyt brYm Kña 2>4 es v a E f T aMG ñk CMg WeG d s _t a m p ÞH n ig t a m sh Km n _

33>> rr))aayykkaarrNN__ffvviikkaa 4> karlM)ak nig]bsKÁ 55>> esckþIsnñidæan

Page 11: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

10

r)aykarN_skmµPaBRbyuT§nwgCm¶WeGds_-kameraK RbcaMRtImasTI 2 qñaM 2011

��������������������

esckþIepþIm ³ r) a yk a rN_en H B iB N’n a B Is m iT i§pl E dl) a nm k BIk a rG nuv t þn _k m µviF Ib g áa r Ef T a Mn ig B üa ) a lCMg W

eG ds _ CMg Wk a m era K en A k ñúgKMe ra g E pn ka rR b ca MRt Im a s T I2 q ña M 20 11 . r) a yk a rN_en H K W) a nb B a© Úln Uv T in ñn ½ yn ig B ½t ’m a n m k B IR Kb ;esv a T aMg G s ;d UcCa esv a E f T aMn ig B üa ) a lCMg W OI/ART m NÐl eF VIet s þQ a m rk em era KeGds _ e da ys µR K½ c it þ nig rk Sa ka rs Mg at ;KøIn ik s uxPa B R KYsa r R k um Ef Ta MG ñk CMg WeG ds _t a m p ÞH nig esva bgáa rk a rcMl g em eraKeG ds _B Im þa yeT A k Unen A T UT a Mg RbeT s Edlc g R k g Ca r) a yk a rN_Ca t i R Kb ; RCug eR Ca ym Yy én k a req øIyt b eT A n wg ka rrIk ra lda lén CMg WeG ds _ -k a m era K k ñúg v i s ½ys u xa Pi) a len A k ñúg Rb eT sk m <úCa . k a rB iB N’n a t a m E pñk Ca bn þbn Þa b ;é nr) a yk a rN_en H KWep þa t elIsk m µPa B sMxa n ;² cM n Yn 3 én k a rG n uv t þn _k m µv iF Ik ñúg k MLú g eB lR tIm a s TI2en H KW³ 1¦sk m µPaB s Mxa n ;²é n k a rR Kb ;R Kg n ig sm iT §p l én k a rG n uv t þn _k m µv iF I 2¦ l T §pl EdlT T Yl) a nB Ik a rp þl;esv a s u xa Pi) a l 3¦r) a yk a rN_én k a rc MNa y Ep ñk h irB a Øvt ßú eR b o beF o bn wg KMera g f v ik a E dl) a n elIk eLIg k ñúg R tIm a sTI2en H. 1> karRKb;RKg nigkarGnuvtþkmµviFI

m CÄm NÐl Ca t iR byuT §n wg CM g WeG ds _ es IE s ,k n ig k am era KKWCa s ßa b ½né n Rk s Yg s uxa Pi) a lE dlm a n t Yn a T Ik ñúg k a rg a rsMrbs MrY lni g ero bcMCa eKa lk a rN_ Ep n k a ryuT §sa R s þeKa l k a rN_E Nn a Mnig n i ya m E b bbT na n a s Mra b ;G n uvt þk m µv iF Ibg áa r E f T a Mn ig B üa )a lCMg WeG ds _- CMg Wk a m era Kk ñúg sßa b ½n s u xa Pi) a l . m CÄm N Ðl Ca t i k ¾m a nt Yn a TIy:a g s Mxa n; k ñúg k a rcl na n ig E bg E ck R bPB Fn Fa n sMra b ;G n uv t þs k m µPaB en A fña k ;Ca t i nig en Af ña k;ext þ e d Im , Is Mer c ) a n nUv sm iT i§pl eT A t a m eKa led A E dl) a nel Ik e LIg k ñúg E pn ka ryuT §s a R s þ rb s ;m CÄm N Ðl Ca t i 201 1 -201 5 nig E pn k a ryuT §s a R sþrbs ; R k s Yg s uxa P i) a lq ña M 20 08 -2 0 15 enA R b eT sk m <úCa .

k > k a rR K b;R Kg KMe ra g CMn Yyé n m Ul n iF isk lk > k a rR K b;R Kg KMe ra g CMn Yyé n m Ul n iF isk lk > k a rR K b;R Kg KMe ra g CMn Yyé n m Ul n iF isk lk > k a rR K b;R Kg KMe ra g CMn Yyé n m Ul n iF isk l m CÄm NÐl Ca t iR b yuT §n wg CMg WeG ds _ es IE s , k n igk a m era K R t Uv ) a n KN³k m µa k a rs Mrb s MrYl KMera g

m Uln iF isk l enA k m <úCa eR CIse rIs Ca k a riya l½yT T YlCM nY ypÞa l;B Im Uln iF is k lbn þeT ot s Mra b ;k mµv iF I Rb yuT §n wg CMg WeG ds _ eR k a m KMe ra g mUln iF is k l SSF. en A k ñúg KMe ra g en H m a nP ña k ;g a rT T YlCM n Y ybn þ T aMg G s ;m a n cMn Yn 2 2 k ñúg e n a H m a ns ßa b ½n cMn Y n 3 f µI E dlm in F øa b ;T T YlCMn Y ym Ul n i F Isk l n ig s ßa b ½n -

Page 12: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

11

G gÁk a rc Mn Yn 1 9 epSg eT o t k MBug T T YlCM n Y ym Uln iF i sk l CMum un ². Pña k ;g a rT TYlCM n Y yb nþé n KMera g m Ul niF isk l cMn Y n 2 2en a H KW G g Ák a r m UlniF iE f T aMCMg W eG ds _ (AIDS Health Care Foundation),

G gÁk a rk m<úCa Gb ;rM n ig Ef Ta MCMg WeGds _ (CRS), G g Áka r Catholic Relief Services bNþa j é n G ñk pÞúk em era KeG ds _-G ñk C Mg WeG ds _ k ñúg R B Hra Ca Na c Rk k m<úCa (CPN+), sm a Km n a rIkm <úCa ed Im ,Isn þiPa B nig G PivD Æn _ (CWPD), Gg Ák a rs uxPa B G nþrCa t i (FHI), G gÁk a rmit þs Mla j ; (FI), G g Ák a rKN³ k m µa F ik a r s Mrbs Mr YlHIV/AIDS (HACC), Gg Áka rxa Na (KHANA), Gg Ák a rem D Ixa M (MEDiCAM), Rk s Yg sg Ám k ic©G t It yuvC n nig y uv n It ism ,T a (MoSVY), G gÁk a rG nþrCa t im :a rIs þúbk m <ú Ca (MSIC), Ga CJa F rCa t i Rb yuT §n wg CMg WeG ds _ (NAA), m CÄm NÐlCa t iR b yuT §n wg CMg WeG ds _ es IE s ,k n ig ka m era K (NCHADS),

m CÄm NÐl Ca t iKa MB a m a ta n ig T a rk (NMCHC), mn ÞIre B T ükum a rCa t i (NPH), G g Ák a rb MerIs u xPa B Rb Ca Cn G n þrCa t i (PSI), sm a Km r:a k ;k m<úCa (RHAC), G g Áka rseR g Áa Hk um a rG UR s þalI (SCA), m nÞI reB T ü RB Hs Ih nu m NÐl én k þIsg Çwm (SHCH), sm a Km n a rI G Piv D Æn _ es d æk ic©n ig G n a m ½y (WOMEN), nig G gÁk a rT s Sn³B iP B elak km <úCa (WVC) .

k m µv iF Ien H m a n eQ µa Hf a k m µv iF Ibg áa r E f TaM C Mg WeG ds _ k a m era K ed Im ,Ib nþs Merc ) a n ka rb gáa rCa sk l en A kñúg Rb eT sk m <úCa E dlm a n eKa lb MNg cMn Yn 7 n ig k m µvt ßúc Mn Y n 20 E d ln w g G n uv t þeda yPña k ;g a r T T YlCMn Y y bn þT a Mg 22en H.

k ic ©RB m eRB og elIKMe ra g mUl n iF Isk l dMNa k ;k a lT I1 en H KWR t Uv ) a n c uHh t ßel xa en A éf ¶T I 25 E x m Ina q ña M201 1 eda ym Uln i F Isk l-h SWE Nv t MNa g R bFa n kit þiys é n KN³ k m µa k a rs Mrb s Mr Yl KMera g m Ul niF isk len A k m <úCa (CCC Chairman) R b Fa n ka riya l½yT T Yl CMn Yyp Þa l;B Im Uln i F is k l¼m CÄm NÐ l Ca t iR byuT §n wg CMg WeG ds _ es I E s ,k nig ka m era K E dlm an ry³ eB l3 q ña M KWB IE xm k ra q ña M 201 1 dl;E xF ñÚ q ña M 201 3 E dlm a n f v ik as rub cMn Y n 85 288 879 dul øa G a em rik n ig E dlCa pøÚv k a rma n c MnYn 81 46 6 687 d ul øa G a em rik E dlk ñúg ena Hm a n f v ik a E dlb n þB IKMe ra g mUln iF isk l CMuT I 7 dM Na k ;k a lT I1 . P ña k ;g a r T T YlCMn Y ypÞa l;B Im Ul n iF is k l -m CÄm NÐ lCa t ies IE s , k n igk a m era K ) a n ero bcMc uH k ic ©RB m eRB og bn þeT ot Ca m Yy P ña k ;g a rTT YlCMn Yyb n þ en A k ñúg E xem sa n ig E x] sPa q ñaM 20 11 .

eda yK Mera g m Uln iF is k l HIV SSF en H) a nG n um ½t eh Iy en A cug E xm ina q ña M 20 1 1e n H e dIm ,IF a n a [) a nn Uv k a rR Kb ;R Kg KMera g m Uln iF isk l en H k a riya l½ yT T YlCMn Y ypÞa l ;B Im Uln iF i sk l¼m CÄm NÐl Ca t i es IE s ,k nig k am era K ) a n ero bc Mk ic ©R bCMut Mrg ;T isry³ eB l 2éf ¶ s þIG MB Ik a rG n uvt þn _KMe ra g m UlniF isk l HIV

SSF CAM-H-NCHADS enA s Næa Ka rG a Mg E T rk ug TIN g ;t a l; k a lBIé f ¶T I 28 n i g 29 E xm if un a q ñaM 201 1 E dls Mrbs M rYl eda y R k um ka rga ré nP ña k ;g a rTT Yl CMn Yy pÞa l;B Im Uln iF isk l ¼ m CÄm N Ðl Ca t i

Page 13: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

12

Rb yuT §n wg CMg WeG ds _ n ig eda ym a n k a rc UlrYm seg át k a r eda yR k um k a rg a rén Pña k ;ga rp þl; CMn YyR bca MRb eT s. sm a Cik Rkum k a rg a rRKb ;R Kg KMera g rbs ;Pña k ;g a rT T YlCMn YyT a Mg Gs ;eR k a m KMera g mUln iF is k l E dl m a n Gñk R Kb ;RKg KMera g R bFa n E p ñkk a rg a r-t am da n nig va yt Mél R bFa n E pñk h irB aØv t ßú nig R bFa n E pñk lT §k m µ ) a nG eB a¢Íj eG a yc Ul rYm k ñúg k ic©R bCMuen H E dlm a n G ñk c UlrYm srubR bE h lCa 1 00 na k ;. eKa l b MNg é n k ic ©R b CuMen H KW³

• pþl;B t ’m a n lMG it G MB IKMera g Single Stream Funding (SSF) CAM-H-NCHADS grant dl;P ña k ;g a rT T YlCM n Y ybn þT a Mg ca s; n ig f µI

• pþl;B t ’m a n lMG it G MB It MrUv k a rk ñúg ka rG n uv t þn _n Uv K Mera g Single Stream Funding (SSF) CAM-H-NCHADS grant dl;Pña k ;ga rT TYlC Mn Yyb nþT a Mg G s ;

• edIm ,Ip þl;k a rE Nn a Mdl ;Pña k ;g a rT TYlC Mn Y yb nþT a Mg G s ; G MBIt MrUv k a rk ñúg k a rerob cMeF VI r) a yk a rN _ Rb ca Mqm a s ¬ Progress Update and Disbursement Request (PU/DR) reporting requirements)

• pþl;B t ’m a n n Uvk a rpøa s ;b þÚrE bbbT xøH²k ñúg k a rG nuvt þn_ KM era g mUl niF isk l • nig k ¾Ca evT ik a m YyE dlG a c e G a y Pñak ;g a rT T YlCMn Y ybn þT a Mg G s ;eF VIk a rbkR sa yn U v s Mn Y r nig

cMelI y E dlT a k ;T g nig bB aða m Yyc M n YnE d lB a k;B ½n§k ñúg k a rG n uv t þK Mera g . x> k a rG n uv t þn _k m µv iF Irb s ;m C Äm NÐl Ca t i x> k a rG n uv t þn _k m µv iF Irb s ;m C Äm NÐl Ca t i x> k a rG n uv t þn _k m µv iF Irb s ;m C Äm NÐl Ca t i x> k a rG n uv t þn _k m µv iF Irb s ;m C Äm NÐl Ca t i ³³³³

eda yf it eR k am ka rRKb ;R Kg rbs ;Rk sYg s uxa P i) a l m CÄ m NÐl Ca t iR byuT §nwg CMg WeG ds _ es IE s ,k nig k am era K m a n t Yn a TIy:a g s Mxa n;Ca s ßa b ½n G n uv t þs k m µPaB s Mra b ;pþl ;Ca k a rga rbec ©k eT s sþIB Ik mµv iF I bgáa r E fT a M n ig B üa )a lCMg WeG ds _-G ñk CMg WeG ds _ d l;é dK Uk a rga rrYm T a Mgk mµv iF IR b yuT §n wg C Mg WeG ds _ -k a m era Ke xt þ-R k ug . eda ye ya g ta m E pnk a ryuT §s a R sþ q ñ a M 201 1 - 201 5 rbs ;m CÄm NÐ lCa t iE dl) a n elIk eLIg n U v sk m µPa B sMxa n ;² en A k ñúg sm a sP a Kn Im Y y² é n Ep n k a ryuT §sa R s þ E dlR t UvG n uv t þeda y m CÄm NÐl Ca t i ext þ -R k ug n ig G g Ák a rG Piv D Æn _na n a .

vd þénk a r eFVIE pnk a r nigk a r ta mda nrbs ;mC ÄmNÐl Ca tiR by uT§n wgC Mg WeG ds _ es IE s , k nig k a mer a K ³

enA k ñúg E x v icäik a q ña M 20 1 0 v KÁs ik ça sa la mYYyE dl) a n er o bc MeLIg eda y E p ñk E p nk a r t a m da n nig r) a yk a rN_én m CÄm NÐl Ca t i s þIB Ik a rB in it üeL Ig v ij n Uv sm iT §iplE dls M erc ) a n k ñúg q ña M 201 0 n ig ero b c M eF VIE pn k a rs Mra b ;q ña M 201 1 eda yE p¥k elI KMe ra g E pn ka ryuT §s a R s þ s Mra b ;k a rG n uv t þn _ k a rbg áa r nig Ef T a MCMg W eG ds _ e n A k ñúg v is ½ys u xa Pi) a l 201 1 -2 01 5 E dlm a n ext þ-ra CF a n I cMn Yn 24 c Ul rYm n ig G g Ák a rCa

Page 14: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

13

édKU. Ca lT §p l KWe yIg T TYl) a n n Uv B R ga g cug eR ka y én K Mera g E pn k a rRb tibt þiR Kb ;RC ug eR Ca ys Mra b ; k m µv iF IR byuT §n wg C Mg WeG ds _ r bs ;m CÄm NÐ lCa t i q ña M 20 1 1 E dl m a n bBa ©Úl nU v inputs and expected

outputs rbs ;G g Ák a rédKU k a rg a rCa m Yyk m µv iF IR byuT §nw g CMg WeG ds _-k a m era K en A f ña k;ext þ -R k ug . KMera g Ep n k a ren H nwg R t Uv yk eT Ab Ba ©ÚleT A k ñúg KMera g Ep n k a rRbt ibtþiR b ca Mq ña M 201 1 rb s ;R k s Yg suxa Pi) a l. Ca c ug eR k a y KMera g E pn ka rR Kb ;R Cug eR Ca y R B m T a Mg KMera gf vik a lMG it E dl m a n T aMg R )ak ;] bt ßm ÖelIk T wk cit þdl ;m R n þIs M ra b ;q ña M 20 1 1 R t Uv) a n G n um ½t . f vik a srub E dl) a n G num ½ t T aMg G s; m a n cMn Yn 19>95 7>08 3 d ul øa G a em rik E dlm a n R bPB f v ika c Mn Y n 1 0R b PB ep Sg Kña s Mra b ;k a rG nuv t þn _sk m µPaB enA f ña k;Ca t i nig f ñak ;ext þ. E p ¥k elIK Mera g E pn k a rRb ca Mq ña M 20 11 en H KMe ra g E pn ka r nig KMera g f v ik a lMG it Rb ca MRt Im a sn Im Yy ² R t Uv ) a n erob cMe LIg Ca lM da b ;lMeda y .

k a r cuH k ic ©R BmeR Bog Ca mYymn ÞIr s uxa Pi) a l ex tþ- R kug ³ KMe ra g E pn k a rRKb ;R Cug eR Ca y n ig KMera g f v ik a lMG it R bc a Mq ña M 20 1 1 rb s ;e xt þ- r a CFa n I R t Uv ) a n

Rb Fa nk mµv iF IeG ds _T a Mg 24 ext þ- ra CF a n I ep JI CUn m k E p ñk Epn k a r t a m da n n ig r) a yk arN_n ig E pñk h irB aØvt ßú én m CÄm N Ðl Ca t iR byuT §n wg CMg WeG ds _ edIm , IB in it üem I leLIg v ij m un n wg da k ;CU n Rb Fa n m CÄm NÐlCa t i G num ½t . ed Im ,IFa n a eG a yk a rR Kb ;R Kg é nf vik aE dlpþl;C Un e da ym CÄm NÐl Ca t i s Mra b ;G nuv t þs k m µPa B Edl) a nelIk eLIg en A k ñúg KMe ra g E p nk a rR bt ibt þiR Kb ;R Cu g eR Ca y q ña M201 1 rbs ;e xt þ-R k ug m CÄm NÐl Ca t i) a n G num ½t elIk a rR Kb ;R Kg E pn ka rG n uv t þk m µv iF IeG d s _-k a m era K q ña M201 1 rb s ;ext þ -R k ug n ig ) a n cuH k ic ©RB m eRB og Ca m YYyR bF a n R Kb ;R Kg k mµv iF IeG ds _T a Mg 24 ext þ-Rk ug . T nÞwm n wg en H G gÁk a rGPivD Æn _n a n a EdlCa sm a Cik R k um k a rg a rbec ©k eT sT ak ;Tg nwg k m µv iF Ibg áa r Ef Ta Mn ig B üa )a lCMg WeG ds _- CMg Wk a m era K ) a n cuHh t ße lxa elIk ic©R B m eRB og Ca m Yym CÄm NÐ lCa t i n ig Ca m Yym n Þ Irs uxa Pi) a le xt þ e d Im ,Ig a yR s Yl k ñúg k a r s Mrbs Mr Yl n ig k ic ©sh k a r k ñúg ka rG n uv t þk m µviF I b g áa r n ig E fT aM CMg WeG ds _ n ig k am era K e nA k ñúg k MLúg q ña M 201 1 en H.

eda yk ic©R B m eRB og el IKMera g mUln iF Isk lr v a g mUln iF I sk l-h SWE Nv n ig k a riya l½yT T Yl CMn Yy pÞa l;B Im Uln iF isk l -m CÄm NÐl Ca t iR b yuT §n wg CMg WeG d s _ es IE s ,k n ig k am era K m a nk a ryWt y:a v rh Ut dl;c ug E x m in a qña M 201 1 eh IyrYm Ca m Yy n wg k a ryWt y:a g kñúg k a rG n um ½t el IKMe ra g f v ik a s Mra b ;k a rbN þúH bNþa ls Mra b ;q ña M 20 1 1en H pg nig eda ysk mµPa B Pa KeR c In Ka MR T eda y f vik a KMera gm Uln iF isk len H e F VI eG a ys k m µPaB swg Et T a MgG s ;R t Uv ) a n p¥a k m a n Et k arpþl; esv a E f Ta M B üa ) a lCMg WeG ds _ CMg Wk a m era K k a reFVIet s þQ a m n ig p þl;R b w k Sa rk em era Ke Gds _ E dl) a n dMe NI rk a rCa F m µt a en a H. xa g eR ka m enH Ca k a r

Page 15: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

14

BiB N’na y:a g lMG it B I sk mµPa B én sma s Pa Knim Yy ² E dl) a n G n uvt þen Ak ñúg R t Im a sen H T a Mg en A fña k ;Ca t i nig f ñak ;ext þ.

1> k mµv iF Ibg áa r E fT a M n igBü a )al b nþ ³ 1111 >>>> e ro b c MÉ k sa eK a lK Mn it s þI B Ik a rbeg áIn k a rT TYl yk e sva pþl ;R b wk Sa n ig eF VIe t s þQ a m rk em e ra Ke ro b c MÉ k sa eK a lK Mn it s þI B Ik a rbeg áIn k a rT TYl yk e sva pþl ;R b wk Sa n ig eF VIe t s þQ a m rk em e ra Ke ro b c MÉ k sa eK a lK Mn it s þI B Ik a rbeg áIn k a rT TYl yk e sva pþl ;R b wk Sa n ig eF VIe t s þQ a m rk em e ra Ke ro b c MÉ k sa eK a lK Mn it s þI B Ik a rbeg áIn k a rT TYl yk e sva pþl ;R b wk Sa n ig eF VIe t s þQ a m rk em e ra K

eG ds _ k ñúg c Me Na m R s þIb Me r Ies v a kMsa n þ n ig b urs rYm eP T C a m Yy b ur s t a m r yeG ds _ k ñúg c Me Na m R s þIb Me r Ies v a kMsa n þ n ig b urs rYm eP T C a m Yy b ur s t a m r yeG ds _ k ñúg c Me Na m R s þIb Me r Ies v a kMsa n þ n ig b urs rYm eP T C a m Yy b ur s t a m r yeG ds _ k ñúg c Me Na m R s þIb Me r Ies v a kMsa n þ n ig b urs rYm eP T C a m Yy b ur s t a m r y ³³³³ k a rGn uv t þn _v iF Is a R s þk a rGn uv t þn _v iF Is a R s þk a rGn uv t þn _v iF Is a R s þk a rGn uv t þn _v iF Is a R s þ p þl ;R b wk Sa n ig eF VIe t s þQ a m rk em era K eG ds _ E d lp þÜc ep þl ;R b wk Sa n ig eF VIe t s þQ a m rk em era K eG ds _ E d lp þÜc ep þl ;R b wk Sa n ig eF VIe t s þQ a m rk em era K eG ds _ E d lp þÜc ep þl ;R b wk Sa n ig eF VIe t s þQ a m rk em era K eG ds _ E d lp þÜc e p þIm eda ysh K m n _ b ¤Rk um R bQ m m ux p þIm eda ysh K m n _ b ¤Rk um R bQ m m ux p þIm eda ysh K m n _ b ¤Rk um R bQ m m ux p þIm eda ysh K m n _ b ¤Rk um R bQ m m ux n wg eR Ka Hf ña k ;x<s ;é n k a rq øg em e ra K eG ds _ n wg eR Ka Hf ña k ;x<s ;é n k a rq øg em e ra K eG ds _ n wg eR Ka Hf ña k ;x<s ;é n k a rq øg em e ra K eG ds _ n wg eR Ka Hf ña k ;x<s ;é n k a rq øg em e ra K eG ds _ ³³³³

enA k ñúg q ña M 20 0 9 n iya m E bb T sMra b ;k a rG n uvt þk a rbg áarE f T a Mn ig B üa ) a lbn þ dl ;Rk um R sIþb Me rIen A esva kMsa n þ enA R b eT sk m <úCa ) a n T T Ylk a rÉk PaB BIR k s Yg s uxa P i) a l eh I ym a n eKa lb MNg Fa n a eG a y ) a nn Uv k a rG n uv t þn _viF a n k a rbg áa reG a ym a nk a rÉk PaB ¬k a reR bIR ) a s ;eR sa m G n a m½y k a reFVIet s þQ a m rk em era KeG ds _ nig k a m era K esv a B nüak MeNIt ¦ nig B R gwg ta m da n ka rs Mrbs MrY l n ig k ic ©sh k a rrv ag bNþa j Ka MR T n ig es va Ef TaMs uxP a B s Mra b ;R s þIb MerI esv a k Msa nþ. niya m E bb bT e nHR t Uv ) a n G nuv t þenA T UT a Mg Rb eT s k¾b :uEn þk a rpþl;R b wk S a n ig eF VIet s þQ a m rk em era KeG ds _ k ñúg c MeNa m R s þIb MerIe s va k Msa n þ n ig b ursrYm ePT Ca m Yyb urs enA B MuT a n ;m a n Pa B l¥R bes Iren A eL Iy. d Uc en Heh I ym CÄm NÐl Ca t iRb yuT §n wg CMg WeG d s _ es IE s ,k n ig k a m era K sh k a rCa mYyé d KU G Piv D Æn _ B ak ;B ½n §n a n a ) a ne ro b cMÉ ksa reKa lKM nit s þIB Ik a r beg áIn k a rT T Yl yk esv a pþl; R b wk Sa n ig eFVIet s þQ a m rk em era Ke Gds _ k ñúg c Me Na m R s þIb Mer Iesv a k Ms a n þ nig b ursrYm ePT Ca m Yyb urs t a m ry³k a rG nuv t þn _v iF Isa R s þpþl;R b w k Sa nig eF VIet s þQ am rk em era KeG ds _E dl pþÜc ep þIm e da ysh Km n _b ¤R k um R bQ m muxn wg eR Ka Hf ña k ;x< s ; én k a rq øg em era KeG ds _ eda yeR b IR ) a s ;n Uv bNþa j é nR s þIeF V Ik a ren A esv a k Msa nþ n ig b Nþa j én R kum b ursrYm ePT Ca m Y yb urs E d l) a n beg áIt eL Ig eda y G gÁk a rd Uc Ca G g Ák a rxa Na / sm a Km r:a k ; n ig Gg Ák a rR KYsa rG n þrCa t i Ca ed Im . b Nþa j T aMg en H n wg pþl;k a r G b ;rMnig CMruj eG a ysm a Cik r b s ;xø Ün beg áIn t Mr Uvk a r é n k a rp þl;R b wk Sa n ig eF VIet s þQ a m rk em era KeG ds _ E d l ) a nc UlrYm R bC Muen A Drop in Centers. Drop in Centers R t Uvyk m k eR bIR ) a s ; Ca k E n øg E dlsm R sb s Mra b ;R k um E dlR bQ m mux n wg eR Ka Hf ña k;x<s ;é n k a rq øg em era KeG ds _ k ñúg k a rcuHp þl ; esva pþl;R b wk Sa n ig e F VI et s þQ a m rk em era KeG ds _ eda ys µR K½ c it þ nig rk Sa k a rs Mg a t ; eda yb uKÁ lik m NÐl s uxPa B . elIsB Ien H G t if iCn E dlT T Yle sva t a mry³ v iF Is a R s þ en HR t Uv ) a n k MNt ;f a Ca R sþIb MerI en A esv a k Ms a nþ b ¤Ca b ursrYm ePT Ca m Yyb u rs.

Page 16: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

15

eR k a yB IÉ k sa e Ka lKMn it ) a n ero bc Meh I y m CÄm NÐl Ca t i nig édK U) a nes ñIs u Mk a rG n um ½t B IR k sYg s uxa Pi) a lk ñúg ka rG n uv t þÉk sa eKa lKMn it s þIB Ik a rbegáIn k a rTT Ylyk esv a pþl;R b wk Sa n ig eF VIet s þQ a m rk em era KeG ds _ k ñúg cMeNa m R s þIb Mer Iesv a k Msa n þ n ig b ursr Y m ePT Ca m Yyb urs t a m ry³ k a rG n uvt þn _viF Is a R s þ pþl;R b wk Sa n ig eF VIet s þQ a m rk em era KeG ds _ E dl pþÜ c ep þIm e da ysh Km n _ b ¤R k um R bQ m mux n wg e RKa H f ña k ;x<s ; é n k a rq øg em era KeG ds _.

x> k a r E fTa MC Mg Wk a mer a K nigk a rb g ár era K ta mR bd a b;eP T ³

s k mµP a BenA fña k;Ca t i ³ 1> k a r er ób er ógÉks ar nigeK a l ka r N_E Nna M ³

k ic ©R b CMuR k um k a rg a rb ec¢k eTss þIB I ka rero bc Mbeg Iát KMr U m :UEdl s Mra b ;da k ;bB a¢Úlk a reF VI G nþra Km n _s þIB Ik a rcMlg em era KeGds _ k a m era K s uxP a Bbn þB UC n ig k a rB n üa k MeNI t sMra b ;R k um R bCa Cn Edlg a yrg eR Ka H .

2> ka r gar G Pi)a l ³ eda ysa rsh k a rCa m YyKøIn i k Ca ties IE s ,k n ig k a m era K m Rn þIE pñk en Hk ¾) a nc u HG Pi) a lka rga rR Kb ;

RKg n ig k a rpþl ;esva Ef Ta MCMg Wk a m era K enA ra CFa n IP ñMeB j n ig t a m bNþa ext þm Yyc MnY n d Uc Ca³ e n A k MB g;c a m t a Ek v es o m ra b eB a F is at ; é b :lin k MB t k MB g;q ña Mg bn Þa ym a n C½ y ) a t ;d Mbg ni g eka Hkug edIm , IB in it ü t a m da n n ig pþl ;CMn Yye lIE pñk b ec©k eT s dl;b uK Álik b Mer I k a rg a ren A KøIn ik k a m era K v ayt Mé llT §pl é nk a r erob cMm n ÞI rB ies a Fn _s Mra b ;es va en H RB m Ta Mg m a n d MeNa H Rs a ynUv bB aða n ig s MNUm B rm YycM n Yn ed Im , IC Mruj eG a yes va E f T aMg CMg W en A KøI n ik k a m era KdMeNI rk a r) a n l¥ n ig m a n R bs iT §iPa B Ef m eT o t (Reports in file) . s k mµP a BenA fña k;ex t þ ³ cuHB in it ün ig B üa ) a lCMg Wk am era Kc l½t Ca ero g ra l;E xdl ;R s þIb Mer Iesv a k Msa nþ enA ; R s uk ) a ra yN_ e xt þk MB g ;F M Rs uk em buN ü n ig s Va yG n Þr e xt þ éR B E vg R s uk QUk ext þk MB t Rs uk PñMR s Yc n ig Kg B is I e xt þk MB g ;s <W Rs uk ) a vit ext þs Va yero g .

2> kBa ©b;s Mr a b;E fTa M n igBü a )al b nþd l;G ñk pÞúk em er a KeG ds _ n igGñk C Mg W eGd s _ k a r E fT aMG ñkC Mg WeG d s _ enA k ñúgmn ÞIr eBT ü ³ ka r er ób erógniy a mE bb T b ¤ eKa l k ar N_E Nn a M ³

Page 17: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

16

Rb eT sk m <úCa Ca R beT sm YyenA k ñúg t Mbn ;) :a s uPik E dl) a n T T YleCa KC ½yk ñúg k a req øIyt bk a r rIk ra lda lé nem era KeG ds _ CMg weG ds _ eda yeF VIeG a yG R t a eR bv :a Lg ;em era KeG ds _ k ñúg cMeNa m R bCa Cn T UeT A E dlm a n Ga yu 1 5 dl; 4 9q ña M F øa k ;c uHB IG R t a 2° en A q ña M 1 998 m k 0/ 7° en Aq ña M 201 0. enA q ña M 201 0 m CÄm NÐl Ca t i) a n e F VIk a r) :a n ;s µa n f a m a nGñk pÞúk em era KeG ds _ cMn Y n 5 620 0 n a k; n ig kñúg cMe Na m enH m a nG ñk pÞúk em era KeG d s _ c Mn Yn 4620 0 n a k ;) a n T T Ylk a rB üa ) a leda y»s f R bq a Mg em era KeG ds _.

en A E xk káda q ña M 201 0 G g Áka rs uxPa B B iPB ela k ) a nE k sMrYl n Uv e Ka lk a rN_E Nn a M s þIB Ik a rE fT a M nig B üa )a leda y»sf R bq aMg em era KeG ds _ s Mra b ;m n us Sca s ; n ig m n us SeB j v ½y ed Im ,IB R g wg n UvK uNPa B én k a rB üa )a leda yEp ¥k elIk a rPs þút ag é nk a rB üa )a l fµI ². G g Ák a rs uxPa B B iPB ela k )a np þl;G n usa sn _ eda yep þa t elIk a rqa b ;e F VIera Kv i n ic ä½ y q a b ;c a b ;epþIm B üa ) a leda y»sf R bqa Mg em era KeG ds _ k a reR CIser Is rUb m n þB üa ) a lE dlm a n plrM xa n t ic t Yc n ig k a rt a m da nEpñk m n ÞIrB iesa F n_s Mra b ;G ñk pÞú k em era KeG ds _ .

enA k ñúg q ña M20 1 1 e n H e Ka lk a rN_E Nn a MT a Mg G s; R t Uv) a n elIk yk m kB in it üEk s MrYle L Ig v ij eda ym R n þIm CÄm NÐ lCa t i n ig édKU T a Mg G gÁP a B rd æa Pi) a l G gÁk a reR kA rd æa Pi) a l n ig m ©a s ;CM n Y y e da y m inE m n E p¥k E t elIG n usa sn _f µI²rbs ;Gg Ák a rs uxPa B BiP Bela k eT b :uE n þk ¾) a n E p¥k eTA elIb T B iesa Fn _E dl ) a nm kBIk a rG nuv t þn_k ñúg ry³ eB l1 0q ñaMk n øg m k pg E dr.

t a m ry³ k ic ©Rb CMuCa bn þbn Þa b ; rbs ;G n u KN³ k m µk a rbec ©k eT s sþIB Ik a rEf T a M n ig B üa )a leda y »sf R bqaMg em era KeGds _ Edlm a nm R n þIE pñk E fT a MCMg We Gds _é n m CÄm NÐ lCa t i ev C¢bN Ðit Edlm k B Im n ÞIr eB T üCa t i nig Gg Ák a rCa é dKU déT eT o t eKa lka rN_E Nn a M m YycM n Yn d Uc xa g eR ka m en H ³

1> eKa lk a rN_E Nn a M Ca t i s þI B Ik a rB üa )a leda y»sf R bqa Mg em era KeG ds _ elIk u m a ren A k ñúg Rb eT sk m <úCa

2> eKa lk a rN_E Nn a M Ca t i s þIB Ik a rB üa )a l CMg W»k a sn iym elIk um a rR bQ m nwg ka rq øg em era K eG ds _ n ig k um a rp Þúk em era Ke G ds _ en A k ñúg R b eT sk m<ú Ca

3> eKa lk a rN_E Nn a M Ca t i s þI B Ik a rB üa )a l CMg W»k a sn iym elIm nus Sca s ;n ig m n us SeB j v ½y Rb Q m n wg ka rq øg em era KeG ds _ nig G ñk p Þúk em era KeGds _ enA k ñúg R beT sk m<úCa

4> eKa lk a rN_E Nn a M Ca t i s þIB I k a rB üa ) a leda y»s f R bqaMg em era KeG ds _ e lIm n us S ca s ; nig m nus SeB j v ½y en A k ñúg R b eTsk m<ú Ca

5 > Ék s a rE NnaMs Mra b ;beR g o nv KÁb N þú Hb Nþa l s þIB Ik a rB üa) a lCMg W»k a sn iym nig k arB üa ) a l eda y »sf R bqa Mg em era KeG ds _

Page 18: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

17

x> es v a p þl;R bwk Sa n igeF VIet s þQ a mr k emer a K eG ds _eda ysµR ½K c itþn igr k Sa ka rsMga t ; sh k a rCa mYyE pñk B ak ;B ½n §n a n a é n m CÄm NÐl Ca t i n ig G g Áka rCa édK U ) a ne ro b cMÉ k sa reKa lKM nit

s þIB I k a rbeg áIn k a rT TYly k esv a p þl;R b wk Sa n ig eF VIet s þQ a m rk em era KeG ds _ k ñúg cMeNa m Rs þIb MerIes v a k Msa n þ n ig b ursr Ym eP T Ca m Yyb urs t a m ry³k a rG nuv t þn _v iF Isa Rs þpþl ;R b wk Sa n ig eF VIet s þQ a m rk em era K eG ds _ E dl pþ Üc ep þIm e da y sh Km n_b ¤R k um R bQ m m ux nwg eR Ka Hf ña k;x<s ;én k a rq øg em era KeG ds _ . 3> kBa ©b ;G eg átt a md a n n igR sa vR Ca v ³

k> k a r G eg átt a mda n ³ 1> k a rG eg át rk G Rt a eRb va Lg ;em era KeG ds _ CM uT I1 0 ³ - erob cMb B a ©ÚlT in ñn½ y s MG a t Tin ñn ½y n ig eF VIk a rv iPa KT in ñn ½ y s Mra b ;k a rG eg át rk G R t a eRbv :a Lg ;

em era KeG ds _C MuT I1 0. - Rb CMuE s Vg rk k a rÉk P aB Kña Ca m YyG ñk CMn a j G n þr Ca t ielI lT §pl én k a rG eg át rk G Rt a eR bv:a Lg ;

em era KeG ds _C MuT I1 0 nig ero bcMp SB Vp Sa ylT §p len H e n A R t Im a seR ka y. 2> k a rG eg át rk G Rt a eRb va Lg ;CMg Wk a m era K q ña M 201 1 ³ - BiF Is a rviF Isa R s þé nk a rR bm Uls MNa k Q a m n ig v tßúv iPa K n ig eKa lk a rN_ENn a M s Mra b ;k a rG egát rk

G Rt a eR bv :a Lg ;CMg Wk a m era K q ña M201 1 R t Uv ) a n ero bc MB in it üeL Ig v ij . - erob cM Check list s Mra b ;k a rcu HR sg ;;s ßit i n ig ed A E pn T I el IRk um eKa ledA s M ra b ;k a rG eg át rk GR t a

eR bv:a Lg ;CMg Wk a m era K q ña M20 1 1. - erob cMk Mrg s MNYr s Mra b ;k a rG eg át rk GR t a eR bv :a Lg ;CMg Wk a m era K q ña M201 1 . - erob cMB iF Isa r s Mra b ;k a rG eg át rk G Rt a eR bv :a Lg ;CMg Wk a mera K q ña M20 11 da k ;CU n dl ;KN³ k m µa k a r

Rk m sIlF m ’edIm , Is Merc n ig G num ½t . - cuHB in it ün ig v a yt Mé ls ßa n Pa B TIt aMg R k um eKa l edA s M ra b ;k a rG eg át rk G Rt a eRbv:a Lg ;CMg Wk a m era K

q ña M201 1 en A ext þ é b :li n k MB g ;s <W ) a t ;d Mbg RB Hs Ih n u k MBg ;ca m ta Ek v éRB E vg n igk MBg ;c a m . x>x>x>x> k a rg a rR sa v R Ca v T a k;T g eT A n wg CMg We G d s _ k a m era Kk a rg a rR sa v R Ca v T a k;T g eT A n wg CMg We G d s _ k a m era Kk a rg a rR sa v R Ca v T a k;T g eT A n wg CMg We G d s _ k a m era Kk a rg a rR sa v R Ca v T a k;T g eT A n wg CMg We G d s _ k a m era K

1> k a rB Rg wg KuNPa B esv a E fT aM n ig B üa ) a lCMg WeG ds _ (CQI) edIm ,It a m da n k a rrIk c MerIn én k a rG n uv t þn _k a rB R gwg KuNPa B esv a EfT aMn ig B üa ) a l CMg WeGds _ (CQI)

Ep ñk R sa vR Ca v cuHeT Ae ro b cMk ic©R bCMus Mrbs Mr Yl Ca m YyR k um k a rg a r OI/ART E p ñkB ak ;B ½n§n a n a én m CÄm NÐl Ca t i n ig é d KUk a rg a r E dleF VIk a rk ñúg ext þn im Y y². k ic ©R bCMuen H KWm a n e Ka lb MNg edIm , IB in it ü

Page 19: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

18

em Ile LIg vij nU v KMera g E pn ka rE dl) a n elIk eLIg bB a ða b ¤ ] bsK Án a n a E dl ) a nCYbR b T Hk ñúg eB lG nuv t þk a r B Rgwg KuNP a B esv a E f T aM nig B üa ) a lCMg WeG ds _en H n ig B iPa k Sa rk d MeNa HR s a yNa E dlsm R sb.

2> k a rsik Sa R sa v R Ca v epSg eTot ³ bn þeF VIk a rs ik Sa R sa v R Ca vep Sg eT ot ed Im ,IKa MRT dl;k a rB üa ) a leda y R bqa Mg em era KeG ds _ E d l k MBug d MeNI rk a rBIq ña Mm un .

4> kBa ©b ;R K b ;R K g ³ k> E pnk a r t a mda n nigr ) a yka r N_ ³

s k mµP a BenA fña k;Ca t i ³ 1> s kmµP a BE pnka r ³

- s Mrbs Mr Yled Im ,Ie ro bc ME pn k a rsk m µPaB Rb ca MRt Im a sT I2 q ña M 201 1 rb s ;m CÄm NÐl Ca t i nig 24e xt þ-R k ug E dlrYm bB a© Úlsk mµP a B lMG it n ig f vik a R Kb ;R bPB T aMg G s;ed Im , IG num ½t .

2> s k mµPa Bt a md a n ³

- ero bc Mr) a yk a rN_R Kb ;R Cug e R Ca yR bc a MR t Im a sT I1 q ñaM20 1 1 E dl) a nda k ;pSa yen A k ñúg eKh T MB ½r rb s;m CÄm N Ðl Ca t i www.nchads.org. . r) a yk a rN_en Hk ¾) a n eF VIk a rE b gE c k eT A Rk s Yg s uxa P i) a l G a CJa F rCa t iR byuT §n wg CMg WeG ds _ m ©a s ;CMn Yy nig éd KUk a rg a r .

- cuHG P i) a lrYm Ca m Y yE pñk R K b ;R Kg »s f n ig s MP a r³ b rik ça r n ig E p ñk KNen yü elIk a rga rR Kb ;R Kg enA ext þ ) a t ;d Mbg E k b k MBt é R B E vg RB Hv ih a r k MB g;s <W k Nþa l eB a F is a t ; s Þwg ER t g Rk ec H rt n KI r I k MBg ;c a m R B HsIh n u m N Ðl KI rI t a E k v bnÞa ym a n C½ y n ig sVa yero g . s k mµP a BenA fña k;ex t þ ³

- k m µv iF IeG ds _e xt þ-R k ug T Mag 24 ) a n ero bc M KM era g E pn ka rR b tibt þiR Kb ;R C ug eR Ca y R bc a M Rt Im a s T I 2 q ña M 201 1 E dl) a n bB a© Úlf v ik a nig lT §plrMB wg T uk BIG g Ák a rCa édKU en A f ña k ;R s uk R b tibt þi nig f ña k ;ext þ.

- erob cMk ic©R bCMus Mrbs MrYl Ca m Yyé dKUk a rg a rnig G gÁk a reRk Ard æa Pi) a lE dleF V Ik a rga reG ds _ enA k ñúg ext þed Im , IE s Vg rk bB aða epSg ² n ig d MeNa HR sa yra l;bB aða E dlek It m a neLIg ed Im ,IeF VI [k a rG n uv t þn _ k m µv iF Irwt E t l¥ .

- ero bc Mr) a yk a rN_R bc a ME x n i g R bca MR tIm a s .

x> E p ñk R K b ;R K gTin ñn ½y³

Page 20: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

19

- R bm UlT in ñn½ y n ig bB a© ÚlT in ñn ½y E pñk STI, OI/ART, VCCT. - v iPa KT in ñ n ½ y nig sresr r) a yk a rN_R bc a MR t Im a sT I2 q ña M 20 11 .

K> E p ñk R K b ;R K g»s fn igs MPa r³ br ikça ³ - ero bc MeF VIb Nѽb eB a ©j n Uv »s f n ig s MPa r³ eT A t am ka lviP a Krbs ; Xøa Mg »s f k Nþa l . - eF VIk a rt a m da n elIk a rE bg Eck »sf OI/ARV n ig s MP a r³R b t ik r - eF VIk a ry:a g Cit s ñiT §Ca m Y yE pñ k lT§k m µk ñúg k a r) :a n ;R bma N»sf OI/ARV s MP a r³ R bt ik r.

2> lT§plEdlTTYl)anBIkarpþl;esvasuxaPi)al

1> sk m µPa B é n ka rT b ;s áa t ;CMg We G ds _1> sk m µPa B é n ka rT b ;s áa t ;CMg We G ds _1> sk m µPa B é n ka rT b ;s áa t ;CMg We G ds _1> sk m µPa B é n ka rT b ;s áa t ;CMg We G ds _

enA R t Im a sT I2 q ña M 20 11 e n H/ m a n m a n KøInik k a m era K (Specialized STI clinic) T a Mg G s;cMn Yn 61 k E nøg ¬ 3 3 k E nøg RKbdNþb ;e lI 21 k ñúg c MeNa m 24e xt þ-R k ug T UT a Mg R beT skm <úCa ¬e lIk E lg ext þk Nþa l/ m NÐl KIr I n ig R k ug Ek b ¦. k ñúg en a H m a n 28 KøI n ik Ca rb s ;G g Áka reR k A rd §a Pi) a l NGO (RHAC=18 KøIn ik,

Marie Stopes=7 K øIn ik,MEC=1 Kø In ik / PSF=1 KøIn ik n ig QUk srKøI n ik = 1 KøIn ik) .

k ñúg c MeNa m 33 KøIn ik k am era KE dl Ca rbs ;rd æa Pi) a l m a n 33 KøIn ik ¬1 0 0 °¦E dl) a n b MB a k;n Uv ]b k rN_bE n ßm s Mra b ;m n Þ IrB ie sa Fn _ E dl Ga ceF VIet s þ RPR n ig Basic microscopy. k úñugc MeNam enH ma n KøI nik cM nYn 3 0 E d lm n ÞIrB ies a Fn _G a cd MeN Irk a r) a n ¬ ] b sm <½n § ] b sm <½n § ] b sm <½n § ] b sm <½n § ³ ³ ³ ³ STI G aMg D Ika T ½r 2G aMg D Ika T ½r 2G aMg D Ika T ½r 2G aMg D Ika T ½r 2 ¦. m n ÞIrB iesa F n_T a Mg en H G a cCYy eG a y eG a yKø In ik k a m era K E dlm in G a c G a ceR b IR) a s;n Uv KMn Us b MR B Yj s Mra b ;k a rR Kb ;R Kg E fT a M nig B üa )a lCMg Wk a m era Keda yB wg E p¥k eT A elIc eg áa m era KsB a Øa s Mra b ;R kum R bCa Cn E dl m a n k a rR bQ mm uxx <s ; [k a n ;E t R besIre LIg .

Ca b En ßm eT A elIk a rg a rrbs ;KøI nik s ux Pa B R KYsa r m NÐl s uxP a B c Mn Yn 210 k E n øg en A k ñúg R suk R b tibt þcMn Yn 71 k ñúg 21 ext þ-R k úg ) a npþl;es va B in it ü CMg Wk a m era Keda yB wg E p¥k eT A el Iceg áa m era Ks B aØa .

k ñúg R t Im a sT I 2 q ña M 20 1 1 m NÐls ux PaB E dlpþl; esv a B in it ü CMg Wk a m era Keda yB wg E p ¥k eT A el Iceg áa m era KsB a Øa kñúg en a HrYm m a n k a rB ieR Ka HCMg W c Mn Yn 1 / 67 0 n a k ; Ca b urs n ig 1 0/ 020 n a k ; Ca R s þI ) a n ra yk a rN_m k k a n;E p ñk R Kb ;R Kg T in ñn ½ yé n m CÄm N ÐlCa t iR b yuT §n wg CMg WeG ds _ es IE s ,k n igk a m era K . k ñúg c MeNa m G ñk CMg Wb ursE dl ) a n ra yka rN_B Iceg áa m era KsBa Øa CMg Wk a m era K c Mn Yn 1 /1 4 7 k rNI k ñúg en a H m a n 1 / 0 62k rNI ¬ 92/ 6°¦ m a n k a rhUrxÞ úHt a m b g ðÜren a m / m a n 67 k rNI ¬5 / 8° ¦m a n d Me) A el I

Page 21: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

20

Rb da b;bn þB UC n ig 1 8 k rNI ¬1 / 6° ¦ s i rm a n ; elIR b da b ;b nþB UC. k a rB init üCMg Wk a m era Keda yB wg E p¥k elI ceg áa m era Ks B aØa c MeB a HR s þIcM n Yn 9/ 40 1 k rNI ; m a n 4 / 75 3 k rNI ¬5 0 / 6° ¦ m a nCMg Wrla k TVa rm a s nig ) a n B üa) a l/ 4/ 279 k rNI ¬45 / 5 ° ¦ ma n CMg Wrla k TVa rm a s nig m a t ;s ,Ún / 287 k rNI ¬3/ 1 ° ¦ m a n CMg Wrl a k E b:lv Is nig 76 k rNI ¬0 / 8° ¦ d Me) A e lIR bda b ;b nþB UC n ig s irm a n ; 6 k rNI ¬0/ 0 6°¦ . k ñúg en a Hm a n édKUE dl ) a nk M Nt ; G t þsB aØa Nf a ma n era Ks Ba Øa n ig )a n B üa )a l e da yB wg E p¥k elIc eg áa m era K sBa Øa en a Hm a n 1 18 7 na k ;Ca b urs n ig 2/ 4 25 n a k ;Ca R s þI.

k a rB ie RKa HCMg Wen A t a m KIø nik k a m era KT a Mg 60 kE n øg E dlm a n KøI nik cMn Y n 33 k E n øg Ca rbs ;rd æa Pi) a l nig KøI n ik G g Áka reR k A rd æa Pi) a lcMn Yn �27 r Ym m a n k a rB ieR Ka HCMg WT a Mg G s; 5 6/ 850 el Ik k ñúg en a Hm a n 4/ 3 61 n ak; Ca b urs n ig 1 / 766 MSM/ 4 0/ 65 2 n ak ; Ca R s þIE dlm a n k a rR bQ m muxT a b nig 1 0>071 na k ; Ca ®s þI eF V Ik a renA es va k Msa n þpÞHbn (BEWs) n ig e F VIk a ren Ae sva kMsa n þ (NBEWs) ¬2 94 na k ; Ca R s þI eF VIk a ren A esv a k Ms a nþp ÞHbn 9/ 777n a k ; Ca R s þIeF VIk a ren A esv a kMs a nþ¦ n ig m a n cMn Yn 4 >62 9 n a k ; m k eF VIk a r Bin it üt a m da n b n þCa ero g ra l;E x ¬ rUb Pa B TI 1 ¦¬ rUb Pa B TI 1 ¦¬ rUb Pa B TI 1 ¦¬ rUb Pa B TI 1 ¦ .

22651770 1476

1051 613 294

63755830

7135

5867 6237

7652

8952 90528450

11616

1051510034 9777

38143240 3290 3577

2980 2885 2730 2643

5609

0

2000

4000

6000

8000

10000

12000

14000

Q1-08 Q2-08 Q3-08 Q4-08 Q1-09 Q2-09 Q3-09 Q4-09 Q1-10 Q2-10 Q3-10 Q4-10 Q1-

2011

Q2-

2011

Total visit of BEW Total visit of NBEW

r Ub P aB T I 1r Ub P aB T I 1r Ub P aB T I 1r Ub P aB T I 1: R sþIe FVIk arenA esv a kM sanþ pÞH b n n ig b Me rIe svakMs an þ E d l) an e T AB in it üsux P aB e n A KøIn ikk ame raK/B IR t Im asT I 1 q ña M 200 8 d l; R t Im a sT I 2 q ñ aM 2 01 1

KøI n ik sm a Km E f Ta Ms uxPa B RKYs a rk m <ú Ca (RHAC) CaKøI n ik m YyE dlT T Ylk a rc a b;G a rm µrN_ nig ) a n T T Yl G t if iCn Pa KeRc I n Ca Rs þIem pÞH rWRs þIE drm a n k a rR b Qmm uxT a b cME Nk ÉKøI nik T a Mg 33 rbs ;rd æa P i) a l

Page 22: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

21

) a np þl;esv a Pa KeR cIn c MeB a HR s þIb Me rIesv a k Ms a n þ. Kø In ik G g Ák a r MEC ) a nT TYlG t if iCnE dr ) a n m k eF VIk a r Bin it ü Pa KeR c In Ca b ursrYm e PT Ca m Yyb urs MSM en A T IR k ug PñMeB j .

k ñúg R t Im a sT I 2 q ña M 201 0 enH Kø In ik T a Mg 5 3 k E nøg k ñúg ena Hc eg áa m era KsB a Øa CMg Wk a m era KE dl) a n ra y k a rN_ m a n G ñk CMg Wb urs cMn Yn 3/ 4 23 k rN I Edlm k eF VI k a rB in it üCMg W bB a ¢a k;f a 3/ 082 k rN I ¬ 90 / 0° ¦ m a n ka rh UrxÞ úHt a m bg ðÜren a m / 7 k rNI ¬0/ 2° ¦ h Ur xÞú Ht a m rn §KUf / 18 7 k rNI ¬5 / 5 ° ¦ dMe) A elIR b da b ; bn þB UC¼ rn§ KUf / 1 28 k rN I ¬3/ 7° ¦ s irm a n ;e lIR bda b ;b nþB UC¼ rn § KUf 7k rNI; ¬ 0 / 2° ¦eh Im R k elo n . ceg áa m era Ks B aØa CMg Wk a m eraK E dl) a n ra yk a rN_k ñúg cMe Na m MSM cM n Yn 4 06 k rNI m a n 272 k rN I ¬67/ 0° ¦ m a n k a rh Urx Þú Ht a m bg ðÜrena m / 1 3 k rNI ¬3 / 2° ¦ h U rx Þú Ht a m rn § KUf n ig 5 4 k rNI ¬13 / 3° ¦ d Me) A elIR bda b ; b nþB UC¼ rn § KUf .

KøI n ik T a Mg 5 3 kE n øg cMeB a HR s þIE dlm a n k a rR bQ m m uxT a b kñúg e na Hc eg áa m era KsB aØa CMg Wk a m era KE dl) a n ra yk a rN_ cMn Yn 43/ 40 0 k rNI;/ m a n 35 / 88 6 k rNI; ¬82/ 7° ¦ m a n CMg Wrl a k T Va rm a s 5 / 245 k rNI; ¬12/ 1° ¦ m a n CMg Wrla k T Varm a s nig ma t;s ,Ún / 1 5 3 k rNI ¬0/ 4° ¦m a n CMg Wrl a kE b :lv Is/ 40 2 k rN I ¬0/ 9° ¦ d Me) A el IR bda b ;bn þ B UC ¼rn §K Uf n ig 1 33 k rNI ¬0/ 3° ¦ s irm a n ; e lIR b da b ;bn þB UC¼ rn §KUf . Rt Im a sT I 2 q ña M 201 1 / k ñúg cMeNa m Rs þIrk s uIp øÚv ePT eda ypÞa l;c Mn Yn 1 2 2 n a k ; ) a n m k eF VIk a rB init üel Ik dMb Ug en A Kø In ik k a m era K m an cMn Yn 1 32 k rN I; ¬1 0 8 / 2° ¦ R t Uv ) a n vin ic ä½yf a m a n CMg Wk a m era K E dl k ñúg en a H m a n 4 5 k rNI ¬3 6 >9 °¦ m a n CMg Wrla k m a t;s ,Ún . c Mn Yn R s þI rk s uIp ø ÚveP T ed a ypÞa l; 1 7 2 na k ; ) a nm kBin it üt a m da n bn þenA KøI n ik k a m era KCa R bc aME x k ñúg en a Hm a n 1 28 k rNI ¬74 / 4 °¦ R t Uv ) a n vin i c ä½ yf a m a n CMg Wk a m era K/ Edlk ñúg en a Hm a n 65 na k ; ¬37/ 7 9° ¦ m a nCMg Wrla k m a t ;s ,Ún ¬ ] b sm <½n § ] b sm <½n § ] b sm <½n § ] b sm <½n § ³ ³ ³ ³ STI G aMg D Ika T½r 1G aMg D Ika T½r 1G aMg D Ika T½r 1G aMg D Ika T½r 1 ¦. k ñúg R t Im a sT I 2- 201 1 R s þIb M erI e sv a kMs a nþc Mn Yn 5 / 3 20n a k ; ) a nm k eFVIk a rB in it ü elIk d Mb Ug en A KøIn ik k a m era K m a n cMn Yn 3/ 76 6 k rN I ¬70 / 8° ¦ R t Uv) a n v i n ic ä½ yf a m a n CMg Wka m era K Edlk ñúg en a Hm a n 1 /5 0 9 k rNI ; ¬ 28/ 4 °¦ m a n CMg Wrla k m at ;s ,Ún . c M nYn R s þ Ib Mer Ies v a k Msa n þ 4/ 45 7 n a k ; ) a nm kBin it üt a m da n bn þ en A KøIn ik k a m era K Ca R bc a ME xk ñúg en a Hm a n 1 / 936 k rNI¬4 3/ 4° ¦ R t Uv ) a n e F VI era Kv i n ic ä½ yf a m a n CMg Wka m era K/ Edlk ñúg en a H m a n 724 k rNI ¬1 6/ 2° ¦ m a n CMg Wr la k ma t ;s ,Ún . cMn Y n lT §p l RPR et s þ T aMg G s; 1 / 882 et s þE dl ) a neF VIk ñúg R t Im a sT I 2 q ña M 201 1 enA m n ÞIrB ies a Fn _ rb s ;KøIn ik T aMg 33 rbs ;r d æ a Pi) a l nig c MnYn 2 eT o t Ca rbs ;Gg Ák a reRk A rd æa P i) a l PSF n ig MEC k ñúg ena Hm a n E t 1 6 ¬0 / 85 °¦) a n rk eXIj m a n RPR v iC¢m a n.

Page 23: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

22

Rt Im a sT I 2 q ña M 20 1 1/ KøI n ik s uxPa B R KYs a r ) a nb B aöÜn G t if iCn eT A k a n;esv a VCCT c MnYn 2/ 21 9 n a k ;/ G ñk pÞúk em era KeG ds _ n ig G ñk CMg WeG ds _c Mn Yn 2 9n a k ; eT A k a n;m NÐl OI/ART/ 5 8n a k ; eT A k a n;es va B in it ü ép ÞeB a Hm un eB ls Mra l n ig 1 5 4 na k; eT A k a n;es va B n üa rk MeNIt . k ñúg en a HE dr KøI n i k s uxPa B R KYs a r k ¾) a n T T YlG t if iCn B Iesv a ep Sg ² pg E drd Uc Ca³ ) a n T T YlG t if iCn c MnY n 6 98 n a k ; B Iesv a VCCT/ 1 45 n a k ; m k BIesv a OI/ART / 84 na k ;m kB Iesv a Bin it üé pÞ eB a Hm un eB ls Mra l n ig 40 na k ; m k BIes va B n üa rk MeNIt .

2> 1 > es va pþl ;R b wk Sa n ig eF VI et s þQ a m eda ys µR½K c it þn ig rk Sa k a rs Mg a t ;2> 1 > es va pþl ;R b wk Sa n ig eF VI et s þQ a m eda ys µR½K c it þn ig rk Sa k a rs Mg a t ;2> 1 > es va pþl ;R b wk Sa n ig eF VI et s þQ a m eda ys µR½K c it þn ig rk Sa k a rs Mg a t ;2> 1 > es va pþl ;R b wk Sa n ig eF VI et s þQ a m eda ys µR½K c it þn ig rk Sa k a rs Mg a t ; (VCCT)

cMn Y n m NÐl pþl ;es va VCCT m a nk a rekIn e LIg y:a g xøa Mg k ñúg ry³ eB l 1 0q ña Mcug e R kayen H/ KWB I 1 2 k E nøg enA q ña M2000 d l; 25 2k E n ø g dl;c ug R t Im a sT I2 q ña M 20 11 ¬ ]b sm <½n §]b sm <½n §]b sm <½n §]b sm <½n § ³³³³ VCCT Ga Mg D Ik aT ½r 1Ga Mg D Ik aT ½r 1Ga Mg D Ik aT ½r 1Ga Mg D Ik aT ½r 1 ¦ ¬ rUb P aB T I2 ¦¬ rUb P aB T I2 ¦¬ rUb P aB T I2 ¦¬ rUb P aB T I2 ¦

r UbP a B TI 2r UbP a B TI 2r UbP a B TI 2r UbP a B TI 2 ³ ³ ³ ³ n in ñak aré n c Mn Yn R bC aCn Ed l)an e F VIe t s þQamr ke m e raKe Gd s_B I q ñ aM 1 9 9 5 d l ;R t Im asT I 1 q ñ aM 2 011

enA k ñúg R tIm a sTI2 q ña M 201 1 en H/ m a nm NÐl VCCT fIµc M n Yn 3 k E n øg EdlR t Uv) a neb Ik eG a yd Me NIrk a r KWe n A m NÐl s uxP a B k MBg ;E lg m NÐls u xPa B é RB E xµr ext þk MB g ;q ña Mg n ig KøIn ik m :a rIs þú b en A ext þes o m ra b . k ñúg c MeNa m m NÐl VCCT T aMg 25 2/ m a n 225 k En øg E dl ) a nT T Yl k a r] btßm Öeda yp Þa l;B Ira C rd æa Pi ) a l/ 27 k E n øg Ca rbs ;G g Áka reR k A rd æa Pi) a l ¬Gg Ák arr:a k ; RHAC: 18, G g Ák a r Marie Stopes: 4, G g Ák a r MEC: 1, G g Ák a r Center of Hope:1, Institute Pasteur: 1 n ig KøI n ik Q Uk s 1 kE n øg ¦.

1 6 712

3651

74

109

140

197212

233246 249 252

0

50

100

150

200

250

300

1995 1996 1997 2000 2002 2003 2004 2005 2006 2007 2008 2009 2010 Q1

2011

Q2

2011

Years

Nu

mb

er

of

sit

es

Page 24: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

23

k ñúg R t Im a sT I2 q ña M201 1 en H/ Gt if iCn VCCT T a Mg Gs ;c Mn Yn 8 9/ 5 95 n ak ; ¬m in m a n T inñn ½y m k B Iesv a k a rbg áa rka rc Mlg em era KeG ds _B Im þa yeT A k Un PMTCT én m CÄm N Ðl Ca t iKa MB a rm at a nig Ta rk NMCHC¦ / m a n Gt if iCn cMn Yn 5 9/ 263 n a k ; ¬66/ 1 ° ¦ ) a n s ½µR Kc it þm k eda yx øÜn Ég / 3/ 1 96n a k; ¬ 3 / 6° ¦ Rt Uv ) a nbB a¢Ún m k eda yk m µvi F IB in it üép ÞeB a Hm un s M ra l (ANC)/ 1 / 8 72n a k ; ¬ 2>1 ° ¦R t Uv) a nB a ¢Ún m k eda y KIø n ik k a m era K/ 4/ 305 na k; ¬4/ 8° ¦ R t Uv ) a n bBa ¢Ún m k eda yk m µviF Ik Mc a t ;era Krebg / 7/ 65 1na k ; ¬6/ 7° ¦ Rt Uv ) a nbB a¢Ún m k eda yR k um Ef Ta Mt a m pÞH (HBC/NGO) 5 / 997n a k ; ¬6/ 7°¦R t Uv ) a n bB a¢Ún m k eda yesv a Bin it ü CMg WT UeT A / 3 20n a k; ¬0 >4 °¦ R t Uv ) a n bB a ¢Únm k eda yesva Ef Ta Mk um a r/ 1/ 34 2n a k ; ¬1 / 5 ° ¦ Rt Uv ) a nbB a¢Ún m k eda yes va s m ÖB / 51 5 na k ; ¬0 >6° ¦ R t Uv ) a n bB a¢Ún m k eda yk m µv i F IE pn k a rR KYsa r nig 5 /1 34 n a k; ¬ 5 >7° ¦ R t Uv ) a n bB a¢Ún m k eda yesv a epS g ²eT o t ¬ r Ub Pa BT I 3 ¦¬ r Ub Pa BT I 3 ¦¬ r Ub Pa BT I 3 ¦¬ r Ub Pa BT I 3 ¦ .

r Ub P a B TI 3r Ub P a B TI 3r Ub P a B TI 3r Ub P a B TI 3 ³ ³ ³ ³ n in ñak aré n cMn Yn Gt if iC n E d l)an e FVIe t sþQam e n AmNÐl VCCT E d lb B a¢Ún BIe sv ae pS g² kñúg R t Im asT I 2 q ñaM20 1 1

cMn Y n srubé nG t if iCnE dl) a n m k eF VIet s þrk em era KeG d s _k ñúg R tIm a s TI2 q ña M20 1 1 m a n 89/ 488 na k;; Ca G t if iCn m k B Iesva VCCT, kñúg ena Hm a n 4/ 20 8n a k ; Ca Gñk CMg Wrebg 5 0 / 95 1n a k; Ca R s þIm a n épÞeB a H ¬48/ 081 n a k; B Iesva sa FarN³ ¦ n ig 1 0/ 478n a k ; Ca b urs Edl Ca é dK Urbs ;R s þ Im a n é pÞeB a H ¬1 0/ 300 BIesv a sa F a rN³ ¦.

Page 25: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

24

enA k ñúg rUbT I4 t a ra g elx1 b gða j B In in ña k a r nig lkçN³ é nG t if iCn VCCT n ig G ñk CMg Wreb g E dl) a n eF VI et s þQ a m rk em era KeG ds _e nA m NÐl VCCT / t Uel x enH K Wm in ra b ;bB a ©ÚlCa m Y yni g R sþIm a n ép ÞeB a HeT . cMn Y n srubé nG t if iCnB I VCCT nig G ñk CMg Webg E dl) a neF VIet s þQ a m rk em era KeGd s _en A esv a VCCT k ñúg Rt Im a sT I2 q ña M 201 1 m a n c MnY n 8 9/ 5 95 n a k ; ¬ r UbPa B T I4 ¦¬ r UbPa B T I4 ¦¬ r UbPa B T I4 ¦¬ r UbPa B T I4 ¦ ....

89,48892,556

88,342

87,520

107,644

80,501

94,40089,522

83,493

83,140

70,518

77,971

71,957

78,922

0

10,00020,000

30,00040,000

50,00060,000

70,000

80,00090,000

100,000110,000

120,000

Q1

2008

Q2

2008

Q3

2008

Q4

2008

Q1

2009

Q2

2009

Q3

2009

Q4

2009

Q1

2010

Q2

2010

Q3

2010

Q4

2010

Q1

2011

Q2

2011

Years

Nu

mb

er

of

pe

op

le t

es

ted

fo

r H

IV

r Ub P aB TI 2r Ub P aB TI 2r Ub P aB TI 2r Ub P aB TI 2 ³ ³ ³ ³ n in ñak aré n cMn Yn R bCaC n E d l)an e FVIe t sþQam rke m e raKe Gd s_e n Ae sva VCCT B IR t Im asT I 1 q ñ aM 2 008 d l;R t Im asT I2 q ñ aM 2 011 cMn Y n srubé nG t if iCn VCCT n ig G ñk CMg Wrebg E dl ) a ne F IVet s þrk em rk em era KeG ds _ kñúg R tIm a s TI 2 q ña M 20 1 1 en H m a n 5 0 / 91 4 na k; ¬5 6 >9°¦ Ca R s Iþ n ig 82/ 825 n a k; ¬9 2/ 4 °¦ m a n G a yuc a b ;B I 15 -49q ña M ¬ ] b sm<½n §] b sm<½n §] b sm<½n §] b sm<½n § ³³³³ VCCT GaMg D Ik aT ½r 2GaMg D Ik aT ½r 2GaMg D Ik aT ½r 2GaMg D Ik aT ½r 2 ¦ ¬ ta rag TI1 ¦.

Gt if iCnE d l mk eF VIetsþQ am r ke mera KeGd s_ People tested for HIV

N= 89,488 No. (%)

Gt ifiCnE d l ma nlT §plQ a mv iC¢ma n People tested HIV positive

N= 1,752 No. (%)

Gay u (Age)

≤14 qña M 2,315 (2.6%) 137 (7.8%)

15-49 qñaM 82,825 (92.6%) 1,510 (86.2%)

> 49 qñaM 4,348 (4.9%) 105 (6.0%)

ePT (Sex)

R b usR b usR b usR b us 38,574 (43.1%) 826 (47.1%)

R sIR sIR sIR sI 50,914 (56.9%) 926 (52.9%)

tttt a ra g T I a ra g T I a ra g T I a ra g T I 1111 ³ lk çN³é n Gt if iCn E dl) an e F VIe t sþQamr ke m e raKe Gd s _e n Ae sva VCCT / kñúg R t Im asT I 2 q ñ aM 2 01 1

Page 26: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

25

enA R t Im a sT I2 q ña M 20 11 e n H/ 98 >8° ¬cen øa H B I 8 8/ 6 °-1 0 0° en AR Kb ; esv a VCCT T a Mg G s ; ¦ én G t if iCn E dl eF IVet s þ rYc ) a nT TYlyk lT §p lrbs ;B Yk eK eda y) a n q øg k at ;k a rpþl;R b wk Sa eR ka yeB l eF IVet s þ ¬ ] b sm <½n ] b sm <½n ] b sm <½n ] b sm <½n ³ ³ ³ ³ VCCT G aMg D Ik a T ½r 3G aMg D Ik a T ½r 3G aMg D Ik a T ½r 3G aMg D Ik a T ½r 3 ¦. enA k ñúg R tIm a sTI 2 q ña M 20 11 en HEdr k ñúg cMeNa m G t if iCn VCCT c M nYn 8 9/ 5 95 na k ; m a n 4/ 3 05 n ak ; ¬4>8 °¦ R t Uv ) a n bB a ¢Únm k BIk m µviF Ireb g ¬ r Ub Pa BT I 5¬ r Ub Pa BT I 5¬ r Ub Pa BT I 5¬ r Ub Pa BT I 5 ¦.

4,178

4,857

5,4955,078

6,0975,694

5,957

7,316

5,935

4,381

5,295

4,6844,2674,305

0

1,000

2,000

3,000

4,000

5,000

6,000

7,000

8,000

1st Q

tr 08

2nd Q

tr 08

3th Q

tr 0

8

4th Q

rt 0

8

1st Q

tr 09

2nd Q

tr 09

3th Q

tr 0

9

4th Q

tr 0

9

1st Q

tr 10

2nd Q

tr 10

3th Q

tr 1

0

4th Q

tr 1

0

1st Q

tr 11

2nd Q

tr11

Year 2011

Nu

mb

er

of

VC

CT

cli

en

ts w

ho

were

refe

rred

by t

he T

B p

rog

ram

r Ur Ur Ur U b P a B TI 5b P a B TI 5b P a B TI 5b P a B TI 5 ³ ³ ³ ³ n in ñak aré n cMn Yn Gt if iCn Ed l)an e F VIe t s þQame n Am NÐl VCCT E d lb B a¢Ún B Ikm µviF Ire bg

cab ;B IR t Im asT I 1 q ñaM 20 08 d l; R t Im as T I 2 qñ aM2 0 11 k ñúg R t Im a sT I2 q ña M 20 11 / R bCa Cn c Mn Y n 8 9/ 5 95 na k ; é nG t if iCn VCCT nig G ñk CMg Wrebg T aMg G s;m a n 1/ 75 2n ak ; ¬2/ 0° ¦ R t Uv ) a n rk e XIj m a n q øg em era KeG ds _v i C¢m a n enA t a m m NÐl VCCT T UT a Mg R beT s

¬ rUb Pa B TI 6 ¦.¬ rUb Pa B TI 6 ¦.¬ rUb Pa B TI 6 ¦.¬ rUb Pa B TI 6 ¦.

Page 27: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

26

21.92.12.3

2.92.62.93.03.13.03.73.74.14.14.5

5.3

6.86.26.6

7.6

9.38.7

9.7

11.7

13.012.5

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

Q1

05

Q2

05

Q3

05

Q4

05

Q1

06

Q2

06

Q3

06

Q4

06

Q1

07

Q2

07

Q3

07

Q4

07

Q1

08

Q2

08

Q3

08

Q4

08

Q1

09

Q2

09

Q3

09

Q4

09

Q1

10

Q2

10

Q3

10

Q4

10

Q1

11

Q2

11

Quarters

HIV

pre

va

lle

nc

e (

%)

r UbP a B TI 6r UbP a B TI 6r UbP a B TI 6r UbP a B TI 6 ³ ³ ³ ³ n in ñak aré n GR t ak arq øg e me rake Gd s_sMrab ; Gt if iCn E d l)an e FVIe t sþQam e n Ae sva VCCT B IR tIm asT I 1 q ñ aM 20 0 5 d l;R t Im asT I2 q ñ aM 2 01 1

2222 >2>2>2>2 ---- esv aB in it ü n ig Büa ) al C Mg We Gd s_ esv aB in it ü n ig Büa ) al C Mg We Gd s_ esv aB in it ü n ig Büa ) al C Mg We Gd s_ esv aB in it ü n ig Büa ) al C Mg We Gd s_ (OI and ART Services)

bc ©úb ,n ñen Hm a n 5 6 k E nøg E dl) a n pþl;esv a k a rB üa )alCMg W»k a sn iym (OI) n ig k a rB üa ) a leda y»sf Rb qaMg em era KeG ds _ (ART) en A k ñúg R s uk Rbt ibt þicMn Yn 4 6 en A k ñúg 21 ext þ-R k ug ¬ ] b sm<½n §] b sm<½n §] b sm<½n §] b sm<½n § ³ ³ ³ ³ CoC G aMg D I G aMg D I G aMg D I G aMg D I

ka T ½r1ka T ½r1ka T ½r1ka T ½r1 ¦. en Akñúg R t Im a senH m a n k E nøg pþl ;esva k a rB üa ) a l CMg W»k a sn iym (OI) n ig k a rB üa )a leda y »sf R bqaMg em era KeGds _ (ART) E dleT Ibn wg beg áIt eh Iyc a b ;ep þ Im dM eNI rk a r KWm a n enA m n ÞIreB T übE g¥k sem þc« n ig m n ÞIr eB T üb Eg ¥k m a n C½y en A ra CF a n IPñM eB j . k ñúg esv a k a rB üa )a lCM g W»k a sniym (OI) nig k a rB üa ) a l eda y»sf R b qaMg em era KeG ds _ (ART) T a Mg 5 6k E n øg en a H m a n 5 2kE n øg )a n T T Ylk a r] bt ßm Ö eda yr d æa Pi) a l n ig 4k E n øg e pSg eT ot eda yG g Ák a rmin E m n rd æa P i) a lCa éd KU ¬ ] b sm <½n §] b sm <½n §] b sm <½n §] b sm <½n § ³ ³ ³ ³ CoC G aMg D Ik a T ½r G aMg D Ik a T ½r G aMg D Ik a T ½r G aMg D Ik a T ½r

2222 ¦. k ñúg c MeNa m esv a B üa ) alT a Mg 5 6 k E n øg e na H m a n 33 k E nøg ) a n T T YlB ini t ü n ig B üa ) a lCMg WCUn k um a rpÞúk em era KeG ds _ enA k ñú g R suk Rb tib t þic MnY n 3 1.

Page 28: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

27

r Ub P aB TIr Ub P aB TIr Ub P aB TIr Ub P aB TI 7777 ³³³³ T It aMg é n m NÐlsux P aB E d lB in it ün ig B üa) alCMg W OI/ART Kit m kd l;E x m if un a q ñ aM201 1

k > k > k > k > k arKa MR TE pñk m nÞIr B ie saF n_k arKa MR TE pñk m nÞIr B ie saF n_k arKa MR TE pñk m nÞIr B ie saF n_k arKa MR TE pñk m nÞIr B ie saF n_ k a rra b;c Mn Y nek a s ik a CD4 m a n 16 / 399 k rNI en A k ñú g Rt Im a sT I2 q ña M20 11 E d leF VIe LIg 8k E n øg KWen A ext þt a E k v/ ext þk MB g;c a m / ext þ) a t ;d Mbg / ext þé R B E vg ¬m nÞI reB T übE g ¥k G ñk elO g ¦/ ext þb nÞa ym a n C½ y/ viT üa s ßa n Ca t iR sa v R Ca v s ux Pa B sa Fa rN³ (NIPH) n ig en A m CÄm NÐ lCa t i ¬PñM e B j ¦ ¬¬¬¬ r UbPa B TI8 ¦r UbPa B TI8 ¦r UbPa B TI8 ¦r UbPa B TI8 ¦ . k a rra b;c Mn Y nek a s ik a CD4 k¾m a n p g E dr en A v iT üa s ßa n ) a:s Þ½r ¬P ñMeB j ¦ m a n cMn Yn 37 3k rNI. k a reF VIet s þ Pa Kry é n CD4 s Mra b ;k um a rR t Uv ) a n eF VIen A v iT üa s ßa n ) a :s Þ½r n ig e nA v iT üa s ßa n Ca t iR sa vR Ca v s uxP a B sa Fa rN³ (NIPH)Rk ug P ñMeB j .

���� CD4 Count Available (8) ���� OI/ART Site (56) ▲Pediatric Site (33)

Page 29: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

28

17,71416,461

18,25116,440 16,588

14,337

17,696 18,505

15,09616,498 16,399

425 373426

357896

572

466400

520405

581

0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

16,000

18,000

20,000

Q4-

2008

Q1-

2009

Q2-

2009

Q3-

2009

Q4-

2009

Q1-

2010

Q2-

2010

Q3-

2010

Q4-

2010

Q1-

2011

Q2-

2011

CD4 tested at 7 government Sites CD4 tested at IPC

r UbP aBT I 8r UbP aBT I 8r UbP aBT I 8r UbP aBT I 8 ³³³³ ninñak ar én cMn Yn kr NIeF IVets þr ab ;ek asik a CD4 Ed l)an eFIVe LIgen A 7 k Enøg c ab ;BIRtIm asT I4 q ñ aM2 0 0 8

r hUtd l;Rt Im as T I2 q ñaM2 0 1 1 enA k ñúg R tIm a sTI2 q ña M201 1 en H enA v iT üa s ßa n Ca t iiR s a vR Ca v s uxPa B s a Fa rN³ m in ) a n eF VI HIV RNA

viral load eT eda yE Lk m a n HIV RNA viral load c Mn Yn 998 k rNI ) a n eF VIe t s þen A v iT üa s ßa n ) a :s Þ½rk m <úCa (IPC).

1,800

1,3111,127

1,4841,310

1,5751,364

1,2181,342

1,139998

0

200

400

600

800

1,000

1,200

1,400

1,600

1,800

2,000

Q4-08 Q1-09 Q2-09 Q3-09 Q4-09 Q1-10 Q2-10 Q3-10 Q4-10 Q1-11 Q2-11

HIV RNA Viral Load tested at IPC

r Ub P aB TI 9r Ub P aB TI 9r Ub P aB TI 9r Ub P aB TI 9 ³³³³ nin ñak aré n c Mn Yn kr NIe F IVe t sþ RNA viral load E d l)an e FIVe L Ig en A viT üa sß an C at iiR s avR C av sux PaB s aF arN ³ n ig

e nAviT üasß an )a:sÞ ½r cab ;B IR t Im a sT I 4 qñ aM2 0 08 rh Ut d l;R t Im asT I2 q ñaM2 0 11 enA k ñúg R tIm a sTI2en H k a reF VIet s þ DNA PCR k ñúg k a reF VIera Kv in icä ½y eG a y) a n qa b ;rh ½s s Mra b ;k um a r m a n 35 3 k rNI ) a n eF VIeLIg en A viT üa s ßa n Ca t iiR sa v R Ca v s uxPa B sa Fa rN³ E dlk ñúg en a Hm a n 1 7k rNIE dl

Page 30: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

29

m a n lT §p lv i C¢m a n n ig enA v iT üa s ßa n) a :s Þ½rm a n DNA PCR c Mn Yn 266 k rNI n ig m a n 13 k r N I m a n lT §p lviC ¢m a n . cMn Yn T a rkE dl) a n R sa vR Ca v DNA PCR el Ik T I1 (excluding DBS for

confirmation) ed Im , IbB a ¢a k; m a n c MnYn 1 75 k rNI E dl k ñúg ena Hm a n T a rk c MnYn 1 2 na k; E dlm a n lT §p l viC ¢m a n en A eB lR sa vR Ca v DNA PCR el Ik T I1 enH n ig m a n HIV DR tested srubc Mn Y n 4 9k rN I. enA c ug R t Im a sT I 2 q ña M20 1 1en H G ñk C Mg Wsk m µsrubc Mn Y n 44/ 72 2n a k ; E dlk ñúg ena Hm a n 4 0/ 436n ak ; Ca m n us SeB j v ½yn ig 4/ 286 na k ; Ca k um a r) a nT TYl ART ¬ r Ub Pa B T I 1 1 / 1 2 ¦¬ r Ub Pa B T I 1 1 / 1 2 ¦¬ r Ub Pa B T I 1 1 / 1 2 ¦¬ r Ub Pa B T I 1 1 / 1 2 ¦¬ ]b sm<½n §]b sm<½n §]b sm<½n §]b sm<½n § ³ ³ ³ ³ HFBC

GaMg D Ik a T ½r 3GaMg D Ik a T ½r 3GaMg D Ik a T ½r 3GaMg D Ik a T ½r 3 ¦.

32

44

49

51

52

11421

51 5456

20,131

12,355

37,315

31,999

26,664

5,974

2,23039271

42,79943,905 44,722

0

10

20

30

40

50

60

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Q1-

2011

Q2-

2011

0

5000

10000

15000

20000

25000

30000

35000

40000

45000

50000

Number of site Number of Active Patients on ART

r Ub Pa B TI 1 1r Ub Pa B TI 1 1r Ub Pa B TI 1 1r Ub Pa B TI 1 1 ³³³³ nin ñak aré n c Mn Yn e s vaB ü a )a lCMg W n ig G ñkC Mg Wskm µTT Y l)an k arB ü a)a le d ay» sf R b q aMg em e r aKe Gd s_ B Iq ña M 2 001 d l;R t Im asT I2 q ñ aM2 0 1 1

40,43639,72938,69737,66636,15834,78433,67732,578

31,01830,080

4,2864,1764,1024,0033,8813,7383,6383,4993,207 3,366

0

5,000

10,000

15,000

20,000

25,000

30,000

35,000

40,000

45,000

Q1-09 Q2-09 Q3-09 Q4-09 Q1-10 Q2-10 Q3-10 Q4-10 Q1-11 Q2-11

Adult Child

r Ub Pa B TI 1 2r Ub Pa B TI 1 2r Ub Pa B TI 1 2r Ub Pa B TI 1 2 ³³³³ nin ñak aré n c Mn Yn Gñk CMg Wskm µC amn usSe B jv½y n ig kum a r B IR t Im asT I1q ñ a M2009 d l;R t Im asT I2 q ñ aM2 011

Page 31: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

30

enA c ug R t Im a sT I2 q ña M20 1 1 en H k ñúg c MeNa m G ñk CMg W s k mµE dlT T Yl) a n k a rB üa )a leda y»sf R bqaMg em era KeG ds _ (ART) m a nRs þIcM n Yn 5 3/ 4° ¬21 / 5 91 ¦. en A t a m m NÐl pþl ;es v a B üa )a l CMg WT aMg G s ; m a n Gñk CMg Wf µIc Mn Yn 1 / 5 90 n a k ; ¬ra b ;b B a© ÚlT aMg k um a r 1 26n a k;¦ ) a n T T Ylk a rB in it ü nig B üa )a lCMg W»k a s niym n ig m a n G ñk CMg Wf µIcMn Yn 1>30 9n a k ; ¬ra b ;bB a ©ÚlT a Mg kum a r 1 31 n a k ;¦) a n c a b ;ep þIm T T Ylk a rB üa )a l eda y»sf R b qa Mg em era KeG ds _(ART) k ñúg R t Im a s TI2 q ña M20 1 1 ¬ r Ub Pa Br Ub Pa Br Ub Pa Br Ub Pa B T IT IT IT I 1 31 31 31 3 ¦. c Mn Y nG ñk CMg W »k a s niym f µI m a nk a rf ycuHbn þ i c eb IeR b o eF o beT A R tIm a sT I1 q ñaM20 11 . eda yE Lk c Mn Yn G ñk CMg WT T Yl k a rB üa ) a l eda y»sf R b qaMg em era KeG ds _ (ART) k ¾m a nk a rf yc uHb nþi c E dr e h Iym a n Gñk CMg WcM n Yn 364 na k ; ) a n e) a Hbg ;ka rB üa ) a l n ig m a n Gñk CMg W 68n a k ; ) a n s øa b ; k ñúg kMLúg e B lB üa ) a lCMg W»k a s niym e n H.

2,265 2,2692,388

2,136

1,847

2,0521,962

1,5301,456

1,5901,634 1,584

1,861

1,607 1,625

1,802

2,124

1,4381,380

1,309

0

500

1,000

1,500

2,000

2,500

3,000

Q1-09 Q2-09 Q3-09 Q4-09 Q1-10 Q2-10 Q3-10 Q4-10 Q1-11 Q2-11

New Patients on OI Care New Patitents on ART

rrrr Ub P a B TI 1 3Ub P a B TI 1 3Ub P a B TI 1 3Ub P a B TI 1 3 ³³³³ nin ñak aré n c Mn Yn Gñk CMg W»k asn iym n ig Gñk C Mg WB ü a) al e d ay»s f R b q aMg e me raKe Gd s_f µI B IR tIm asT I1q ña M200 9 d l; R t Ima sT I2 q ñ a M201 1

m a n CMg W»k a sn iym s k m µc MnY n 5 / 75 1 na k ; Ca m n us SeB j v ½y n ig 1 / 4 31 n ak; Ca k um a r E dlm inT a n;m a n lk çN³ sm R sbs Mra b ;T T Ylk a rB üa ) a leda y»s f R bqa Mg em era KeG ds _enA e LI yeT rh Ut m k dl;cug Rt Im a sT I2 q ña M 201 1 e nH. k ñúg c M eNa m G ñk CMg WT a Mg G s;m a n 4 >5 38n a k ; ¬ 64 / 4 °¦ Ca R s þIE dl Pa KeRc In b þI rWé dKU rbs ;B Yk eK) a nT T Ylk a rB üa )a lCMg W OI/ ART eR c I n q ña Mm k eh Iy.

Page 32: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

31

cMn Y n srubé nG ñk CMg W»k a sn i ym Ca m n us SeB j v½ yc Mn Yn 1 >035 n a k ; n ig k um a rc MnYn 1 93n a k ; m a n lk çN³ sm R sb n wg T T Yl) a n k a rB üa ) a l eda y»sf Rb qaMg em era KeG ds _ E t B MuT a n;) a nT T Yle nA c ug E xm if un a q ña M 201 1 en H .

x> k a rc l ½t Gñk CMg W t a m es va epSgx> k a rc l ½t Gñk CMg W t a m es va epSgx> k a rc l ½t Gñk CMg W t a m es va epSgx> k a rc l ½t Gñk CMg W t a m es va epSg ² ² ² ² e) a Hbg ;k a rB üa ) a l n ig s øa b ;e) a Hbg ;k a rB üa ) a l n ig s øa b ;e) a Hbg ;k a rB üa ) a l n ig s øa b ;e) a Hbg ;k a rB üa ) a l n ig s øa b ; enA c ug R t Im a sT I 2 q ña M20 1 1 en H/ m a n G ñk CMg Wc Mn Y n 27 6n a k ; E dlT T Yl) a n k a rB üa) a leda y»sf R bqaMg em era KeG ds _ (ART) R t Uv) a n bB a¢Ún e c j eT A k a n;es va ART f Iµ Edls ißt en A Cit pÞ H b ¤k E nøg rs ;en A rbs ;B Yk eK . eh I yn ig m a n G ñk CMg WE dlk MB ugB üa ) a leda y»sf R bqa Mg em era KeG ds _cM n Yn 31 4n a k; ) a ne) a Hbg ; k a rB üa ) a l nig 1 48 na k ;epSg eT ot )a n s øa b ; enA k ñúg R t Im a sen H. m k dl;c ug R t Im a s enH m a n esv a p þl; k a rB üa ) a l eda y»sf R b qaMg em era KeG ds _c M n Yn 1 0 Edlm a nG ñk CMg Wsk mµT T Yl) a n k a rB üa )a leda y »sf R bqaMg em era KeGds _eR c In Ca g 1 / 000 n ak; k ñúg ena Hm a n en A m n ÞIreB T üm it þP a BE xµr -s Uev o t ¬P ñMeB j ¦ m a n Gñk CMg Wsk mµk MBug T T Yl) a n ka rB üa )a leda y»sf Rb qaMg em era KeG ds _c Mn Y n 3/ 675 na k;.

K> k a rK a MR T E p ñk »s f n wg sm Öa rK> k a rK a MR T E p ñk »s f n wg sm Öa rK> k a rK a MR T E p ñk »s f n wg sm Öa rK> k a rK a MR T E p ñk »s f n wg sm Öa r ³³³³ b rik çab rik çab rik çab rik ça

enA c ug R t Im a sT I2q ña M 201 1 en H R Kb ;m N Ðl ART T aMg G s ; ) a neF VIr) a yk a rN_ c MnY n G ñk CMg Wt a m rUbm n þ »sf ART n im Y y ². ev C¢ b Ba ¢a eRb IR ) a s;rUbm n þ »sf Pa KeR c I n KW d4t+3TC+NVP, d4t+3TC+EFV nig AZT+3TC+NVP eda ym a n 3 >8 ° én m n us SeB j v½y n ig 7>9 ° é nk um a rR tUv ) a n T T YlrUbm n þ»sf PI-

Based ¬t a ra gT I2¦ .

rUb mnþ énka reR b IR ) as;»sf ARV ,

Q2. 2011

m nusSe B jv ½y N= 41,419*

No. (%)

k uma r N= 4,321*

No. (%)

d4t+3TC+NVP 16,656 40.2 % 3,142 72.7 %

d4t+3TC+EFV 5,485 13.2 % 406 9.4 %

AZT+3TC+NVP 10,879 26.3 % 308 7.1 %

AZT+3TC+EFV 4,128 10.0 % 109 2.5 %

PI-based regimens 1,593 3.8 % 341 7.9 %

Other regimens 2,678 6.5 % 15 0.3 %

*T in ñn ½yrUb m n þé n kare R bIR )as ;»s f m in ) an R twm R t UvB it R )akd C ak;E sþ g e T An wg cMnUn t Yr e lx rb s;GñkC Mg W ART e T .

t ara g T I t ara g T I t ara g T I t ara g T I 2222 ³ e vC¢b B a a¢s þIB Ik ar e R b IR) as ; n wg k arE ckca yr Ub mn þ»sf R b q aMg e me raKsMr ab ;Gñ kpÞú ke m e raK HIV e n Akm <úC a kñúg R t ImasT I 2q ñ aM 2 01 1

Page 33: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

32

X> X> X> X> k a reF VIet s þR sa v R Ca v rk CMg Wr ebg e lIG ñk CMg WeG ds _f µIk a reF VIet s þR sa v R Ca v rk CMg Wr ebg e lIG ñk CMg WeG ds _f µIk a reF VIet s þR sa v R Ca v rk CMg Wr ebg e lIG ñk CMg WeG ds _f µIk a reF VIet s þR sa v R Ca v rk CMg Wr ebg e lIG ñk CMg WeG ds _f µI enA k ñúg R tIm a sTI 2 q ña M20 1 1 enH m a n G ñk CMg WeG ds _ f µI ¬T a Mg m n us Sc a s; n ig k um a r¦ E dl ) a nc uHeQ µa H enA k E nøg E dl pþl;esv a B üa )a lCMg W»k a sn iym n ig T T Ylk a rB üa ) a leda y»sf R bqMa g em era KeG ds _ m a n cMn Y n 1 / 5 90n a k; . en A k ñúg cMeNa m G ñk CMg W»k a sn iym f µI Ca m n us Sc a s ;c Mn Yn 1 / 4 64 en a H m a nG ñk CMg W »k a sn iym c Mn Yn 1 / 1 1 57n a k ; ¬7 9>1 ° ¦) a n eF VI e t s þR s a vR Ca v rk CMg Wrebg . Ca lT §pl m a n Gñk CMg W cMn Y n 191 n a k ; ) a n eFVIet s þR sa v R Ca v rk CMg Wreb g eh Iym a n lT §p lCMg Wrebg s Yt (BK+/-) nig CMg Wrebg eR k A sYt (EPTB) en A kñúg cMe Na m Gñk CMg WE dl ) a n eF VIera Kv in i cä½ yf a m a nCMg Wreb g Ta Mg 1 91 n a k ;en H m a nG ñk CMg W 1 84n a k ; ) a n T T Ylk a rB üa ) a lCMg Wrebg . ka reF VIet s þR sa vR Ca vrk CMg Wrebg en A k ñúg cMeNa m G ñk CMg W eG ds _f µIen H m a n k a rf ycuH eb IeR b o b eF o beT A nwg Rt Im a sT I1 q ña M 20 11 ¬9 4> 7° ¦e da ysa rR Kb ;esv a OI/ART T a Mg G s;) a n eF VIk arR sa v R Ca v CMg Wrebg t a mka rR sa v R Ca vCMg Wreb g t a m ry³ e ra KsB a Øa (Symptom

Screening) . g > g > g > g > k a rG n uv t þn _yuT §sa R s þ k a rG n uv t þn _yuT §sa R s þ k a rG n uv t þn _yuT §sa R s þ k a rG n uv t þn _yuT §sa R s þ Three "I"

1111 >>>> k a rB üa ) a l bgáa rC Mg Wr ebg eda y» sf k a rB üa ) a l bgáa rC Mg Wr ebg eda y» sf k a rB üa ) a l bgáa rC Mg Wr ebg eda y» sf k a rB üa ) a l bgáa rC Mg Wr ebg eda y» sf Isoniazid (IPT)

enA k ñúg R tIm a sTI 2 q ña M20 1 1 enH m a n Gñk CMg WeG ds _»k a sniym f µIc Mn Yn 962n a k ; E dl) a n cu HeQ µa Hen A esva OI/ART T aMg 29k E n øg E dl) a n c a b ;ep þIm G nuv t þn _n Uv yuT §sa R s þ Three "I" en H ¬c M nYn 6k E nøg EdleF VIet s þT u yE b ‘Kuyl In e lIE s ,k m a n G ñk CMg W 265 na k; n ig c Mn Yn 2 3k E n øg ep Sg eT ot E dlm in m a n k a reFVIet s þT uyE b ‘ Ku yl Ine l IEs ,k m a n G ñk CMg W 697 n a k ;¦. k ñ úg c MeNa m G ñk CMg W T aMg G s ;enH m a n G ñk CMg W cMn Y n 1 40 n a k ; ) a n ca b ;epþI m B üa )a l bgáa reda y»sf Isoniazid ¬c Mn Y n 6k E n øg EdleF VI et s þT uyE b ‘ Ku y lIne l IEs ,k m a n G ñk CMg W 1 7n a k ; n ig cMn Y n 23 k E n øg epSg eT o t E dlm in m a n ka reF VIet s þT u yEb ‘Kuyl In elIE s ,k m a n G ñk CMg W 1 23n a k ;¦ nig m a n G ñk CMg Wc MnYn 268 na k ; k MB ug T T Ylk a rBüa ) a lbg áa reda y»sf Isoniazid ¬ c Mn Yn 6k E n øg EdleF VI et s þT uyE b ‘ Ku ylIn e l IEs ,k ma n Gñk CMg W 24 na k ; n ig cMn Yn 23k E nøg epSg eT ot E dlm in m a n k areF VIet s þT u yE b ‘Kuyl In el IE s ,k m a nGñk CMg W 244 n a k ;¦k ñúg cMeNa m Gñk CMg W »k a sn iym cMn Yn 7/ 0 5 0 na k ;.

2222 >>>> mmmm unc a b ;ep þIm k a rB üa ) a l e da y» sf R b qaMg em e ra K eG ds _ unc a b ;ep þIm k a rB üa ) a l e da y» sf R b qaMg em e ra K eG ds _ unc a b ;ep þIm k a rB üa ) a l e da y» sf R b qaMg em e ra K eG ds _ unc a b ;ep þIm k a rB üa ) a l e da y» sf R b qaMg em e ra K eG ds _ enA k ñúg R tIm a sTI 2 q ñ a M2 0 1 1en H m a nG ñk CMg WeG ds _ f µI c Mn Yn 1 / 46 4n a k; E d l) a n cuHeQ µa H en A esv a B üa )a lCMg W»k a sn iym n ig k a rB üa ) a leda y»sf R bq Mag em era KeG sd _. k ñúg c MeNa m G ñk CMg Wen H m a n Gñk CMg WcM n Yn 1 / 1 5 7n a k ; E dl ) a n eF VIk a rBin it üs u xPa B rk era KsB aØa CMg Wreb g m a n G ñk CMg Wc MnYn 46 7n a k ; E dl y:a g eh a c Na s ; m a n era KsB a Øa mYyk ñúg cMe Na m era Ks B aØa T a Mg 3 k ñúg ry³ eB l 4 s) a þh_ k n øg m k ¬m a n

Page 34: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

33

RKun ek þA k ¥k nig E bk ej Is eCa K xø Ün en A eB l yb ; r y³eB l 2s) a þh _k nøg mk¦. k ñúg cMeNa m G ñk CMg W Edlm a nera KsB aØa CMg Wrebg viC ¢m a n T Ma g 46 7n ak ;enH m a n 1 91 na k ; E dl) a n eF VIera Kvin ic ä½yf a m a n CMg W re bg (BK+/-) b¤m a nreb g eR k A sYt eh Iym a n Gñ k CMg W 1 84n a k ; ) a n ca b ;epþIm k a rBüa ) a lCMg Wrebg c MENk G ñk CMg WcMn Yn 14 0n a k ;eT o t ) a n ca b ;epþ Im k a rB üa) a lbg áarC Mg Wrebg eda y»sf Isoniazid (IPT) ena H R t Uv bn þeda yG ñk CMg WT a Mg ena H m in T a n ;m a n era KsB aØa CMg Wreb g . m a n Gñk CMg WE dlk MB ugB üa ) a lCMg W»k a sn iym cMn Y n 21 5 n a k; ) a neF VIera Kv in i cä½ yf a m a n CMg Wrebg (BK+/-) b ¤m a n reb g eRk A s Yt k ñúg en a Hm a n Gñk CMg W 192 n a k ; ) a n c a b;ep þIm B üa ) a lCMg Wreb g eh Iym a n G ñk CM g Wrebg -eG ds _ 1 13 na k ;eT o t ) a n TT Ylk a rB üa ) a lbg áa reda y»sf cotrimoxazole n ig 268n a k ; ) a nc a b ;e pþIm k a rB üa )a lbg áa reda y»sf Isoniazid (IPT) .

3333 >>>> k a rB üa ) a l eda y» sf R bq aMg em e ra K ek a rB üa ) a l eda y» sf R bq aMg em e ra K ek a rB üa ) a l eda y» sf R bq aMg em e ra K ek a rB üa ) a l eda y» sf R bq aMg em e ra K e G ds _ G ds _ G ds _ G ds _ enA k ñúg R tIm a sTI 2 q ña M20 1 1 enH m a n G ñk CMg WeG ds _; cM n Yn 1 / 178n a k ; E dl) a nT T Ylk a rB üa )a leda y »sf R bq Mag em era KeGs d_f µI . kñúg cMeNa m en H m a n G ñkCMg Wc M n Yn 97 n a k ; E dl) a n eF VIera K vin ic ä ½yf a m a n CMg W re bg b ¤rebg eR k A s Yt eh Iyk ñúg en a Hm a n G ñk CMg W 6 8n a k ; E dl) a n c a b ;ep þIm B üa ) a lCMg Wrebg . m a n Gñk CMg W Edlk MB ug B üa )a l»sf R b qa Mg em era KeG ds _c Mn Yn 1 73 n a k; ) a n eF VIe ra Kvi n ic ä½ yf a m an CMg Wr ebg (BK+/-) b ¤m a n rebg eRk A sYt k ñúg enaHm a n G ñk CMg W 1 26 na k ; ) a n c a b ;ep þIm B üa ) a lCMg Wrebg eh Iym a n G ñk CMg Wrebg -eG ds _c M n Yn 1 1 4n a k ; eT o t ) a n T T Ylk a rB üa ) a lbgáa reda y»sf cotrimoxazole.

4444 >>>> k a rm a n é p ÞeB a H n ig k a rrMl Ut k a rm a n é p ÞeB a H n ig k a rrMl Ut k a rm a n é p ÞeB a H n ig k a rrMl Ut k a rm a n é p ÞeB a H n ig k a rrMl Ut ³ ³ ³ ³ enA k ñúg R tIm a sTI 2 q ña M20 1 1en H m a n G ñk CMg WeG ds _ f µICa R s þIc M nYn 795 n a k ; E dl) a n cuHeQ µa H en A esv a B üa )a lCMg W»k a sn iym n ig B üa )a leda y»sf R bq Ma g em era KeG sd _ eh Iyk ñúg en a H m a n G ñk CMg WeG ds _ Ca Rs þIcMn Yn 86n a k ; m a n ép ÞeB a H. m k dl;c ug R tIm a sen H k ñúg c MeNa m G ñk CMg W Ca R s þIc Mn Yn 4 / 5 38n a k; E dlk MBug B üa )a lCMg W»k a sn iym m a n R s þI 11 4 na k ;m a n ép ÞeB a H n ig kúñg en a Hm a n 48 na k ; ) a n T T Yl»sf ARV s Mra b ; k a rbg áa rka rc Mlg em era KeG ds _B Im þa yeT A k Un . ma n G ñk CMg W 1 n ak ; ) a n ra yka rN_f a ) a n rl Ut kUn eda y Ék É g nig 1 n ak;eT o t ) a n eF VIk a rrMlUt . enA k ñúg R tIm a sTI 2 q ña M20 1 1 en H m a n Gñk CMg WeG ds _ Ca R s þIc M n Yn 6 36n a k ; E dl) a n T TYlk a rB üa )a leda y »sf R bq Mag em era KeGs d_f µI eh I yk ñúg ena Hm a n G ñk CMg WeG ds _Ca R s þIc MnY n 4 7n a k ; m a n épÞeB a H. m k dl;cug Rt Im a sen H kñúg cMeNa m G ñk CMg WCa R s þI c Mn Yn 21 / 5 91n a k ; E dlk MBug TT Ylk a rB üa )a leda y»sf R bqaMg em era KeG ds _ m a n R s þI 1 6 0n a k ;m a n ép ÞeB a H . m a n G ñk CMg W 7n a k ; ) a n ra yk a rN_ f a ) a n rl Ut kUn eda y Ék É g nig 4 nak ;eT o t ) a n eF VIk a rrMlUt .

Page 35: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

34

2> 3 2> 3 2> 3 2> 3 ---- KMe ra g v iF Isa R s þeq øI yt br Ym KñaKMe ra g v iF Isa R s þeq øI yt br Ym KñaKMe ra g v iF Isa R s þeq øI yt br Ym KñaKMe ra g v iF Isa R s þeq øI yt br Ym Kña enA k ñúg R tIm a sTI2- 20 11 e n H m a n Rs uk R bt ibtþic M n Yn 6 2 E dl ) a nG n u v t þv iF Isa R s þeq øI yt brYm K ña

Et kñúg ena Hm a n E t Rs uk Rbt ibt þic Mn Yn 5 5 b:ueN Ña H E dl) a n epJIr) a yk a rN_m k m CÄm NÐ l Ca t i . Kit c a b ;B I E x em sa m k dl;E x m if un a q ña M 201 1 en H m a n R s þIm a n é p ÞeB a Hsrub c MnY n 74 / 67 9 na k; E dl) a n m k TT Yl esva E fT a Mép ÞeB a HelIk T I1 en A esva Edlm a nk mµviF Ieq ø Iy t brYm Kña n ig t a m ry³ k a r cuHG b ;rM k ñúg en a Hm a n R s þI cMn Y n 5 6/ 240 na k ; ¬75 / 30° ¦) a n eF VI et s þQ a m rk em era KeG ds _ n ig m a nb þI b ¤é dK UcMn Yn 1 2/ 36 2na k ; Edls µRK½ c it þeF V Iet s þQ a m rk em era KeG ds _E dr ¬21 / 98° é nR s þIm a né p ÞeB a H) a neF VIet s þQ a m rk em era K eG ds _ Ca m Yyb þIb ¤é d KU rbs ;B Yk eK¦. k ñúg cMe Na m Rs þIcMn Yn 74 / 67 9n a k ; E dl ) a neF VIet s þQ a m rk em era K eG ds _e na H m a n R s þI 82 n a k ; ¬0>1 7 °¦ E dlm a n pÞ úk em era KeG ds _ n ig R s þIm a n é pÞeB a Hc Mn Y n 21 n a k ; E dl ) a nd wg BI l T §pl rb s ; xøÜ nf a m a n p Þúk em era KeG ds _en a H e h Iy) a n c Ul rYm enA k ñúg k m µv iF I eq øIyt brYm Kña .

Ca s rub m a n R s þIm a n é pÞeB a HE dlm a n pÞúk em era KeG ds _ cMn Y n 1 1 8n a k ; k ñúg c MeNa m R s þIE dlm a n ép ÞeB a Heh Iym a np Þ úk em era K eG ds _) a n m k s Mra lk Unrb s ;BYk eK en A k ñúg m n ÞIrsm ÖB E d lm a n esv a ka t;bn ßy k a rc Mlg em era KeG ds _B Im þa yeT A k Un . kñúg c MeNa m R s þI C a m þa ycMn Yn 11 8n a k ;ena H m a n R sþIc MnYn 11 3 na k ; ¬95 / 76° ¦) a n T T Ylk a rB üa ) a leda y»sf Rb qa Mg em era KeG ds _ k ñúg ena Hm a n 8 1 na k ; ¬ 76/ 86° ¦ k MBug B üa) a leda y»sf R bqa Mg em era KeG ds _ (HAART) nig 32n a k; ¬30/ 5 5 °¦ ) a n T TYl»sf ARV

s Mra b ;k a rB üa) a lbg áa r. k ñúg c MeNa m T a rk 1 23n a k ; E dl ek It B Im þa ym a n pÞúk em era KeG ds _ en A k ñúg m nÞI rs m ÖB E dlm a n esv a

k at ;bn ßyk a rcMl g em era Ke Gds _B Im þa yeT A k Un n ig en A eR k A E dlk ñúg en a H m a n s Mra len A pÞH nig enA b :us þ i s uxP a B m a nT a rkE t 111 na k; ¬ 90/ 24° ¦ E d l) a n T T Ylk a rbgáa reda y»sf R bq aMg em era KeG ds _ K W »sf NVP .

2222 >>>> 4444 ---- esv a E f T aMG ñk C Mg WeG d s _e n A t a m sh K m n _esv a E f T aMG ñk C Mg WeG d s _e n A t a m sh K m n _esv a E f T aMG ñk C Mg WeG d s _e n A t a m sh K m n _esv a E f T aMG ñk C Mg WeG d s _e n A t a m sh K m n _ (Community-based Services)

es va Ef Ta MGñk CMg We G ds _t a mp ÞHes va Ef Ta MGñk CMg We G ds _t a mp ÞHes va Ef Ta MGñk CMg We G ds _t a mp ÞHes va Ef Ta MGñk CMg We G ds _t a mp ÞH (HBC services)

Rt Im a sT I2 q ña M 201 1 m an R kum E f Ta Mt am pÞH c Mn Yn 33 8R k um E dlR Kb dNþb ; 861 m NÐls uxPa B enA k ñúg R suk Rb tibt þicMn Yn 71 en A k ñug ext þc M nYn 1 9 (]b s m <½n §]b s m <½n §]b s m <½n §]b s m <½n § ³ ³ ³ ³ HBC Ga MgD Ik a T ½r1Ga MgD Ik a T ½r1Ga MgD Ik a T ½r1Ga MgD Ik a T ½r1 ¦ . ¦ . ¦ . ¦ . en A k ñúg R tIm a sen H ext þ RB Hvih a r B uMm a n r) a yk a rN_rbs ;R k um E f Ta MeT eR B a HG g Ák a rE dl) a n G nuv t þelIk a rg a rEf Ta MenH ) a n c b ;

Page 36: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

35

KMe ra g kñúg k a rR KbdNþb ;n ig E f T aMG ñk p Þúk em era KeG ds _ni g Gñk CMg WeG ds _ eh I yn ig k MB ug rk GgÁk a rf µIm k CMn Ys ¬rUbPa B T I 1 3¦ .

338357356353331342

328

375343

320

271

244

337323

861861848841

753761742

706

675678

686680 716

700

0

50

100

150

200

250

300

350

400

Q1-

08

Q2-

08

Q3-

08

Q4-

08

Q1-

09

Q2-

09

Q3-

09

Q4-

09

Q1-

10

Q2-

10

Q3-

10

Q4-

10

Q1-

11

Q2-

11

400

450

500

550

600

650

700

750

800

850

900

Number of Teams Number of HC covered by HCB Teams

r UbP a B TI 1 3r UbP a B TI 1 3r UbP a B TI 1 3r UbP a B TI 1 3 ³³³³ n in ñak aré n R kum E f TaMt am pÞ H (HBC teams) B IR t ImasT I 1 q ñ aM 2 008 r hUt R t Im a sT I 2q ña M 2 011

Rk um E f T a Mt am p ÞH (HBC) Ta Mg G s;) a n CYyE f T a M Ka MR T ] bt ßm Ödl;G ñk pÞ úk em era K G ñ k CMg WeG ds _sk m µcMn Yn 31 / 41 7n a k; (]b sm <½n §]b sm <½n §]b sm <½n §]b sm <½n § ³ ³ ³ ³ HBC G aMg D Ika T½r 2G aMg D Ika T½r 2G aMg D Ika T½r 2G aMg D Ika T½r 2) k ñúg en a HG ñk E dl) a n eF VIk a rcuHbB a ¢IT T Ylka rB üa ) a lCMg W »k a sn iym(OI) m a n cMn Yn 7/ 5 4 0n ak ; nig G ñk CMg W ART E dl ) a ne F VIk a rc uHb B a ¢Im a n 23/ 877n a k ; .

3>r)aykarN_hirBaØvtßú ³

k > seg çb r) a yk a rN _c MNa y R K b ;R bP B f v ik a EdlR K b ;R K g eda ym CÄm N ÐC a t i k > seg çb r) a yk a rN _c MNa y R K b ;R bP B f v ik a EdlR K b ;R K g eda ym CÄm N ÐC a t i k > seg çb r) a yk a rN _c MNa y R K b ;R bP B f v ik a EdlR K b ;R K g eda ym CÄm N ÐC a t i k > seg çb r) a yk a rN _c MNa y R K b ;R bP B f v ik a EdlR K b ;R K g eda ym CÄm N ÐC a t i ³³³³ enA k ñúg R tIm a sen H f v ik a cMNa yeT A elIk m µviF Ibg áa r n i g Ef Ta MKa MR T Gñk CMg WeG ds _ ) a n R bE h lCa

5 1 ° eb IeF ob eT A nwg KMera g E p nk a rR tIm a s TI 2 q ña M 201 1 enH EdlR t Uv) a n c M Na yeT A elIsk m µPaB s Mxa n; ² én k m µv iF I bg áa r E f T aM n ig B üa )a ldl;G ñk pÞúk em era KeG ds _ n ig G ñk CMg WeG ds _ . k a rc MNa yen H m a n kMrit T a b eda ys a rf v ika P a KeR c In KW m in T a n ;) a n cM N a ys Mra b ;k a rp Át ;pÁg ;»s f ni g s MPa r³ brik ça r eh Iy Ca B iess KW »sf Rb t ik r n ig s MPa r³ brik ça r ¬t a ra gT I 3¦. m :üa g vij eT o t s k mµPa B xøHs Mra b ; Ka MR T esva E fT a M n ig B üa )a l bn þdl ;Gñk pÞúk em era KeG ds _¼G ñk CMg WeG ds _ Rt Uv) a nG n uv t þe n A R s uk R bt ibt þi c Mn Yn 1 1 én ext þ c Mn Yn 1 0 ¬k MB g ;F M kMB t k Nþa l é RB E vg sVa ye ro g eB a F isa t; ] t þrm a n C½ y s Þwg ER t g RB Hs Ih n u nig t a Ek v¦ eR ka mk a rKa MR T fv ik a eda ym Uln iF IE f T a MCMg WeG ds _ (AHF) n ig 4 ext þ ¬ ) a t ;d Mbg / bn Þa ym a n

Page 37: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

36

C½ y/ eB aF isa t; nig é b :lin ¦ eh Iysk m µPa B dé T eT ot E dlen A sl;s Mra b ;e xt þ-R k u g e pSg ² en a HR tUv ) a n Ka MR T f v ika eda yKMe ra g m Uln i F Isk l .

r) a yk a rN_en H bg ða j BIk a rcMNa yeF o beT A n wg KMera g Ep n ka rR tIm a s. en A k ñúg t a rag é n k a rc M Na y E dl) a n elIk yk m k en H m a n E t ka rc MNa y E dlm a n en A k ñúg RbB ½n §KN en yü rbs ;m CÄm NÐl Ca t i b :ueN Ña H. m a nR b PBf vik a RbE h lCa 10 E dlen A eR ka m k a rR Kb ;R Kg rb s ;m CÄ m NÐlp Þa l;d U c Ca ³ KMera g m Uln iF isk l ¬ T I5 n ig HIV-SSF¦ CDC, CHAI, UNSW/CTAP, CIPRA, WHO, AHF, CRS, PSI . Sources Annual Plan Q2 Plan Q2 Act Q2% A %

GFATM-HIV-SSF $18,406,927 $11,949,949 $6,271,405 52% 34%

GFATM-R5 $ 38,840 $ 22,581 $ 56,622 251% 146%

US-CDC $ 501,868 $ 418,777 $ 228,204 54% 45%

AHF $ 122,312 $ 27,631 $ 49,578 179% 41%

WHO $ 50,000 $ 6,015 $ 5,886 98% 12%

CHAI $ 299,623 $ 881,574 $ 82,148 9% 27%

UNSW(CTAP) $ 7,183

CIPRA $ 86,053

CRS $ 19,454 $ - $ - 0% 0%

UNICEF $ 200,000 $ - 0% 0%

PSI $ 20,000 $ - $ - 0% 0%

Grand Total $19,659,024 13,306,527 $6,787,079 51% 35%

t a ra g T It a ra g T It a ra g T It a ra g T I 3333 ³ ³ ³ ³ seg çbk a rc MNa yt a m R bPB f v ik aseg çbk a rc MNa yt a m R bPB f v ik aseg çbk a rc MNa yt a m R bPB f v ik aseg çbk a rc MNa yt a m R bPB f v ik a E dl RK b ;R K g eda ym CÄm N ÐlC a t iE dl RK b ;R K g eda ym CÄm N ÐlC a t iE dl RK b ;R K g eda ym CÄm N ÐlC a t iE dl RK b ;R K g eda ym CÄm N ÐlC a t i

4>karlM)ak nig]bsKÁ

eT a Hb ICa m a n ka ryWt y:a v k ñúg k a rp þl;f v ik a sMra b ;k a rG n uv t þn _k m µv iF I E t sk mµPa B caM) a c;m Yyc M nYn B ies s k a rpþl ;esva eF VIet s þQ a m rk em era KeG ds _ k a rB üa ) a l n ig E fT aM dl ;G ñk p Þúk em era Ke G ds _ G ñk C Mg WeG ds _ eda yk m µviF I Ca t i en A E t bn þC a Fmµt a . k a ryWt y:a v k ñúg k a rG n um ½t elIk a rpþl;f vik a elIk T wk cit þd l;b uK Álik eF V IeG a ym a n k arb :HB a l;dl;s ña éd k a rg a r B ies sen Ak E nøg pþl; es va .

Page 38: Final Report Q2 2011 in khKN³ k m kµ a rsrM bsrM Y lk m vµ i FeI R b RI ) a se; R sa m G na my½ 1 00 ° CUP Condom-Use Programme km vµ Fi eI R bRI ) a se; R s a mG na m y½ 1

37

5>esckþIsnñidæan Ca rYm s wg E t R Kb ;T ised A é n s Uc n a k rE dlT a k ;T g nwg k arp þl; esv a T a Mg G s;d Uc Ca es v a OI/ART,

VCCT, STI, and HBC services E dl)a n elIk eLIg k ñúg R tIm a s TI 2 q ña M 20 11en H ) a n s Merc eT A t a m Ep n k a rrbs ;m CÄm NÐl Ca t i. T n Þwm Kña en H eda ym a nk a rKa MR T BIé dKUG Piv D Æn _ m CÄ m NÐl Ca t i ) a n xit x M Rb wg ER bg k ñúg k a relIk k MBs ;Ku NPa B esva Ef Ta M n igB üa ) a len H t a m ry³ k a rG nuv t þn _ Continuum of Quality Improvement n ig k a rt a m da n GaMg D Ik a T ½rR b k asG a s nñ ed Im ,IeF V Iy :a gNa eGa yKu NPa B esv a OI/ART k a n ;E t m a nP aB Rbes Ie LIg .